ЛЕКАРСТВЕННАЯ КОМПОЗИЦИЯ ДЛЯ ЛЕЧЕНИЯ БРОНХИТА И СПОСОБ ЕЕ ПОЛУЧЕНИЯ

Изобретение относится к фармацевтической промышленности, в частности к фармацевтической композиции для лечения бронхита. Фармацевтическая композиция для лечения бронхита содержит порошок SCUTELLARIAE RADIX; эфирное масло, полученное из смеси растений CITRI RETICULATAE PERICARPIUM и CINNAMOMI RAMULUS; сконцентрированный водный экстракт, полученный изтравяного остатка, оставшегося после получения эфирного масла, и смеси растений, состоящей из ATRACTYLODIS MACROCEPHALAE RHIZOMA, PORIA, GLYCYRRHIZAE RADIX ET RHIZOMA, FARFARAE FLOS, FORSYTHIAE FRUCTUS; сконцентрированный этанольный экстракт из PINELLIAE RHIZOMA, PERILLAE FRUCTUS, SINAPIS SEMEN, RAPHANI SEMEN, ASTERIS RADIX ET RHIZOMA, HOUTTUYNIAE HERBA, ARMENIACAE SEMEN AMARUM.Заявленная фармацевтическая композиция эффективна в устранении мокроты, облегчении кашля, ослаблении астмы, а также сопротивлении воспалению, и оказывает хороший лечебный эффект при лечении бронхита. 10 з.п. ф-лы, 15 табл., 12 пр.

КОМБИНАЦИЯ АКТИВНЫХ ИНГРЕДИЕНТОВ МАСЕЛ, СОДЕРЖАЩИХ W3-ЖИРНЫЕ КИСЛОТЫ, С РАСТИТЕЛЬНЫМИ ЭКСТРАКТАМИ, СОДЕРЖАЩИМИ ПОЛИФЕНОЛЫ, И ИХ ПРИМЕНЕНИЕ

... 1. Комбинация активных ингредиентов, включающая, по меньшей мере, одно масло, содержащее W3-жирные кислоты, и, по меньшей мере, один растительный экстракт, содержащий полифенолы, причем растительный экстракт, содержащий полифенолы, представляет собой экстракт из Vitis vinifera. 2. Комбинация активных ингредиентов по п.1, отличающаяся тем, что масло, содержащее W3-жирную кислоту, содержит альфа-линоленовую кислоту. 3. Комбинация активных ингредиентов по п.2, отличающаяся тем, что масло, содержащее W3-жирную кислоту, выбрано из группы, включающей перилловое масло, масло бораго, масло семян вечерней примулы, рыбий жир, льняное масло и масло семян черной смородины. 4. Комбинация активных ингредиентов по любому из пп.1-3, отличающаяся тем, что растительный экстракт, содержащий полифенолы, содержит, по меньшей мере, 15% полифенолов в расчете на вес сухого вещества. 5. Применение комбинации активных ингредиентов по любому из пп.1-4 для лечения, повышения эффективности лечения и для профилактики ...

ПРЕПАРАТ ИЗ МАСЕЛ ДЛЯ КОРРЕКЦИИ СОСТАВА МИКРОБИОТЫ КИШЕЧНИКА В ФОРМЕ КАПСУЛЫ С КИШЕЧНОРАСТВОРИМОЙ ОБОЛОЧКОЙ

Изобретение относится к области химико-фармацевтической, нутрицевтической промышленности и медицины и касается средства, корректирующего нарушения функционирования микробиоты. Препарат для коррекции состава микробиоты кишечника в форме мягкой капсулы, характеризующийся тем, что содержит оболочку, включающую желатин пищевой, глицерин, альгинат натрия, гидроксипропилметилцеллюлозу, стеариновую кислоту и аммония гидроксид, в которую заключено действующее начало в виде комплекса из масла листьев мяты перечной, эфирного масла корневищ имбиря, токоферола или смеси токоферолов, а также масла, выбранного из оливкового масла рафинированного, масла периллы или их смеси, при следующем содержании компонентов в мг на капсулу: желатин пищевой 110-130, глицерин 43-50, гидроксипропилметилцеллюлоза 22,5-27,5, альгинат натрия 4,7-5,3, аммония гидроксид 0,9-1,1, стеариновая кислота 0,3-0,7, эфирное масло корневищ имбиря 10-500, мяты перечной листьев масло 10-500, токоферол или смесь токоферолов 0,04-0,06, ...

Arzneimittel zur Behandlung von Erkältungen und Verfahren zu seiner Herstellung

Die vorliegende Erfindung offenbart ein Arzneimittel zur Behandlung von Erkältungen und das Verfahren zu seiner Herstellung. Das Arzneimittel zur Behandlung von Erkältungen umfasst 10 - 20 Gewichtsteile Fructus forsythiae, 10 - 15 Gewichtsteile Perilla-Blätter und 3 - 20 Gewichtsteile Dandelion. Das erfindungsgemäße Arzneimittel zur Behandlung von Erkältungen weist verglichen mit den Arzneimitteln des Standes der Technik andere Komponenten auf und vermag die Nachteile der Arzneimittel des Standes der Technik zu beseitigen.

Combination of an antiallergic agent with muscarinic antagonist and/or dopaminergic agonist for use in preventing/stopping of axial myopia in human

One of the major issues against the use of muscarinic antagonists or dopamine agonist eyedrops for the controlling of eye growth and prevention of myopia is the unacceptable rate of iatrogenic conjunctivitis or dermatitis. This invention relates to the association of those active principles with an antiallergic component. In alternative the ophthalmic use of a molecule that simultaneously has an antimuscarinic and/or dopaminergic action along with an antihistaminic function.

Health food capsules with efficacy of assisting in reducing blood fat and preparation method thereof

本发明涉及一种具有辅助降血脂功效的保健食品胶囊及其制备方法。所述保健食品胶囊包括如下重量份的原料：紫苏油250～350份、黑加仑油100～200份、维生素E 0.4～1.0份、明胶50～100份和甘油20～50份。配方原料间作用相互协同，且经动物、人体临床实验证实对于辅助降血脂有显著的效果。所述制备方法简单易操作：仅需将紫苏油、黑加仑油和维生素E混合后装填胶囊壳即可，制备方法可复制性强，有利于规模化生产。

Chinese traditional medicine for treating cough and variable asthma after cold and its preparation

Medicine and food dual purpose Chinese medicinal nutritive product for preventing and treating skin carbunculosis sore toxin and its manufacturing method

Composition for preventing, ameliorating or treating dermatitis comprising complex of natural oil and natural extract treated with anion generated by plasma as effective component

The present invention relates to a composition for preventing, alleviating, or treating skin inflammation comprising a complex of natural oils and natural extracts treated with anions generated by plasma as an effective component. More specifically, the composition of the present invention comprises, as an effective component, a complex formed by mixing an oil mixture of sunflower seed oil, perilla seed oil, and apricot seed oil, with a mixed extract containing peony, morus bark, Angelica gigas, Shrubby sophora, gardenia, mugwort, Saururus chinensis (Lour.) Baill., Houttuynia cordata, Acanthopanax sieboldianum MAKINO, milkwort, and Cimicifuga heracleifolia KOM., and treating the mixture with anions generated by plasma. The composition of the present invention has excellent effects in reducing the LPS-induced formation of nitric oxide (NO) and reducing the expression of inflammatory cytokines, iNOS and IL-1β, and thus may be beneficially used as a cosmetics product, a functional health food, or a therapeutic agent for preventing or alleviating skin inflammation.

Composition for Anti-allergy Using Extracts of Ulmus davidiana and Perillae Folium

본 발명은 유근피 추출물 및 자소엽 추출물을 이용한 항알러지용 조성물을 개시한다. 본 발명의 조성물은 아토피 피부염(atopic dermatitis), 천식(asthma), 알러지성 비염(allergic rhinitis), 알러지성 결막염(allergic conjunctivitis), 알러지성 피부염(allergic dermatitis), 알러지성 접촉성 피부염(allergic contact dermatitis) 또는 알러지성 각막염의 치료 등에 유효하게 사용될 수 있다.

Pharmaceutical Formulation for Preventing or Treating Inflammatory Diseases Comprising Isoegomaketone

COMPOSITION FOR PREVENTING OR TREATING STERILITY COMPRISING EXTRACT OF PERILLA FRUTESCENS

The present invention relates to a composition for preventing or treating sterility, a composition for promoting pregnancy, or a composition for enhancing implantation capacity, and more specifically, to a composition for preventing or treating sterility, a composition for promoting pregnancy, or a composition for enhancing implantation capacity of an ovum within the uterus, all of which comprise an extract of Perilla frutescens as an active ingredient. The extract of Perilla frutescens according to the present invention increases expressions of leukocyte inhibitory factor (LIF) and integrins αvβ3 and αvβ5, promotes attachment of fetal trophoblast cells with endometrial cells, thereby increasing implantation efficiency within the uterus, and therefore, can be beneficially used for preventing or treating sterility. COPYRIGHT KIPO 2016 ...

PREPARATION METHOD OF REMEDIAL COMPOSITION FOR PROMOTING HAIR GROWTH AND PREVENTING HAIR GREYING

The present invention relates to a preparation method of a remedial composition for promoting hair growth and preventing hair greying, wherein the preparation method comprises: a raw material selection step for preselecting Houttuynia cordata, Perillae folium, green tea leaves, Cynanchum wilfordii, and peppermint, and removing contaminants and undesirable parts thereof; a washing step for drying the selected materials to prepare dry leaves of Houttuynia cordata, dry leaves of Perillae folium, dry green tea leaves, dry roots of Cynanchum wilfordii, and dry peppermint, and washing the dried materials with water; an extraction step for placing the washed materials in a bag and then introducing the washed materials and distilled water into a concentrating apparatus to extract a concentrated liquid; a pressing step for pressing the materials in the extraction step to separate residual concentrated liquids; a distillation step for distilling the concentrated liquids at 100°C or above, and then ...

COMPOSITION CONTAINING GRAINS, FRUITS AND VEGETABLES, SEAWEED AND MUSHROOMS FOR INHIBITING HYPERLIPIDEMIA

PURPOSE: A composition containing grains, fruits and vegetables, seaweed and mushrooms for inhibiting hyperlipidemia is provided, therefore the blood HDL(high density lipoprotein) level can be increased, and LDL(low density lipoprotein) level, neutral lipid and total cholesterol levels can be decreased, to inhibit deposition and increase of cholesterol and neutral lipid in blood. CONSTITUTION: The composition contains grains, fruits and vegetables, seaweed and mushrooms for inhibiting hyperlipidemia, wherein the grains consist of 10 to 50 wt.% of unpolished rice, 5 to 15 wt.% of germinated unpolished rice, 1 to 4 wt.% of glutinous millet, 1 to 4 wt.% of African millet, 0.5 to 3 wt.% of job's-tear, 1 to 4 wt.% of beans, 0.2 to 1 wt.% of black sesame, 0.01 to 1 wt.% of unpolished glutinous rice, 0.01 to 1 wt.% of black rice and 0.01 to 1 wt.% of barley; the fruits and vegetables consist of 5 to 20 wt.% of kale, 1 to 3 wt.% of carrot, 0.5 to 2 wt.% of burdock, 10 to 50 wt.% of old pumpkin, ...

A NASAL COMPOSITION

The present invention relates to a nasal composition comprising an anti-allergic oil derived from plant; and an oil-based barrier-forming preparation. The composition may be used in preventing and/or treating allergic disorders of the nasal cavity, including seasonal allergic rhinitis (hay fever) and perennial allergic rhinitis.

VERWENDUNG OMEGA-3-FETTSÄUREHALTIGER ÖLE ZUR ERHÖHUNG DER BIOVERFÜGBARKEIT VON PFLANZENEXTRAKTEN

Composition, useful for improving skin- and bone condition, comprises fat oils from seeds of black nettle (Perilla frutescens), vitamin C, vitamin E, calcium, vitamin K1 and vitamin D3

Composition, for improvement of skin- and bone condition, comprises fat oils from seeds of black nettle (Perilla frutescens), vitamin C, vitamin E, calcium, vitamin K1 and vitamin D3. ACTIVITY : Dermatological; Osteopathic. No biological data given. MECHANISM OF ACTION : None given.

Interferon inducers, methods for their preparation pharmaceutical compositions containing them and their use as medicaments

An interferon inducer isolated from the plant tissue, having an elemental analysis of H: 8.5-8.7 %, C: 48.8-49 %, N: 6.3-6.5 % and P: 1.0-1.1 % and a molecular weight of from about 100,000 to about 3,000,000 (mainly about 200,000 to about 1,000,000) and containing as main constituents amino acids, sugars and phosphoric acid. This substance is believed to be a homogeneous polymer of protein and sugars, containing phosphoric acid. This substance has an excellent interferon inducing activity and low toxicity and is significantly active against various viruses. The interferon inducer may be produced by extracting a substance having interferon inducing activity from the tissue of a plant of the genus Perilla of the family Labiatae or a variant thereof containing said active substance and recovering the active substance from the extract thereby obtained. Preferably, the extraction may be effected with water and the recovery may be effected by ultrafiltration. Pharmaceutical composition of this ...

ETHEREAL OIL CONTAINING PREPARATION

FORMULA AND PROCESSING TECHNOLOGY OF CYCLOCARYA PALIURUS LEAF WEIGHT-REDUCING HOT COMPRESS MEDICINE BAG

The present invention discloses a formula of a Cyclocaryapaliurus leaf weight reducing hot compress medicine bag. The Cyclocaryapaliurus leaf weight-reducing hot compress medicine package formula comprises the following components by mass: 150-200g of Cyclocarya paliurus, 20-30g of borneol, 10-15g of lotus leaves, 10 15g of poria cocos, 10-15g of rhizoma alismatis, 10-15g of coix seeds, 10-15g of perilla leaves, 10-15g of astragalus membranaceus, 10-15g of Chinese waxgourd peel, 10-15g of fresh ginger, 10-15g of white hyacinth beans, 10-15g of hawthoms, 15-20g of leonurus, 6-10g of ligusticum wallichii and 3-5g of raw rhubarb. The present invention further discloses a processing technology of a Cyclocarya paliurus leaf weight-reducing hot compress medicine bag. The processing technology comprises the following steps of (1) pre-treatment of raw materials; (2) crushing; (3) proportioning and mixing; and (4) packaging. The Cyclocarya paliurus leaf weight reducing hot compress medicine bag ...

Extracts of perilla frutescens seeds and their pharmaceutical uses

EXTRACTS OF PERILLA FRUTESCENS SEEDS AND THEIR PHARMACEUTICAL USES Abstract Disclosed is an extract of Perilla frutescens seeds that contains rosmarinic acid, luteolin, and apigenin, the weight ratio between rosmarinic acid, luteolin, and apigenin being 0.1-200 : 0.1-200 : 1. Also disclosed is a method for treating a psychiatric disorder using the above-described extract or an extract of Perilla frutescens seeds containing at least an active agent selected from the group consisting of rosmarinic acid, luteolin, and apigenin.

COMPOSITION FOR ENHANCING HYALURONIC ACID PRODUCTIVITY AND METHOD FOR PREPARING SAME

A composition for enhancing hyaluronic acid productivity particularly in epidermic cell or tissue composed of the cell, which contains an extract of a plant belonging to the family Labiatae as an active ingredient, and a process for preparation thereof. Particularly, there is provided a cosmetic or pharmaceutical composition which can be safely and directly applied to human skin to maintain the normal skin function of a juvenile.

Traditional Chinese medicine extract and preparation for preventing asthma and preparation method thereof

Freeze dried perilla tea (powder) and application of freeze drying process in producing perilla tea

Preparation method of purple perilla extract

Food containing radix tetrastigmae or herba tetrastigmae

Health products having blood fat and blood pressure reducing functions and manufacturing method thereof

The health product with functions of reducing blood fat and lowering blood pressure is prepared with refined ginseng oil, red pine seed oil and purple perilla oil in the weight ratio of 1 to 3-7 to 12-16, and through mixing, stirring for 20-40 min and packing. The health product of natural materials has simple production process, low cost and no side effect.

Ointment treating for dermatophytosis

PHARMACEUTICAL COMPOSITION FOR ANTI-CANCER CONTAINING MEDICINAL GERB EXTRACTS

COSMETIC AND PHARMACEUTICAL COMPOSITIN COMPRISING SASA QUELPAERTENSIS EXTRACT AND UREA

comprimidos flutuantes de liberação modificada contendo óleo essencial de mentha crispa

SPRAYING AGENT FOR PREVENTING AND TREATING ALLERGIC ASTHMA COMBINED WITH ALLERGIC RHINITIS IN CHILDREN AND TEENAGERS

Disclosed is a spraying agent for preventing and treating allergic asthma combined with allergic rhinitis in children and teenagers. The spraying agent comprises pharmaceutical ingredients and auxiliary materials. The pharmaceutical ingredients comprise volatile oils and a traditional Chinese medicine extract, wherein the volatile oils comprise Annona squamosa seed volatile oil, Citri reticulatae pericarpium volatile oil, Aquilariae lignum resinatum volatile oil, Perillae fructus volatile oil, Lonicerae japonicae flos volatile oil and Borneolum syntheticum; and the traditional Chinese medicine extract is prepared from Sinapis alba, Chrysanthemi flos, Viticis fructus, Ampelopsis grossedentata, Puerariae lobatae radix, Scutellariae radix, Ephedrae herba preparata, fried Xanthii fructus, Polygoni cuspidati rhizoma et radix and Salviae miltiorrhizae radix et rhizoma.

METHOD OF ADMINISTRATING A SERIES OF COMPOSITIONS FOR DYNAMIC IMMUNE MODULATION

The present disclosure provides a series of compositions, or a single composition formulation (e.g., which includes distinct time release portions), supportive of or resulting in antipode immune system effects. A method of administrating the series of compositions or the single composition formulation to support, provide, enhance, or improve health benefit by way of modulating aspects immune system function is also provided.

CHINESE MEDICINE FOR TREATING DIGESTIVE SYSTEM ULCERATION AND PREPARATION METHOD THEREOF

Disclosed are a Chinese medicine for treating digestive system ulceration and a preparation method thereof, wherein the medicine is made of snakegourd frui, caulis perllae and dried orange peel, each at 30-40 parts by weight, rhizoma, corydalis yanhusuo and bamboo shavings, each at 25-35 parts by weight, concha arcae, hedyotis diffusa, cuttlebone and allium macrostemon each at 20 to 25 parts by weight, earthworm, radix sophorae tonkinensis and melia toosendan each at 10-15 parts by weight, and catechu at 5-10 parts by weight.

TRADITIONAL CHINESE MEDICINE COMPOSITION FOR RECOVERY PHASE OF EXOGENOUS FEVER, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF

A traditional Chinese medicine composition for recovery phase of exogenous fever and a preparation method therefor. The traditional Chinese medicine composition comprises the following raw materials: radix codonopsis, rhizoma atractylodis macrocephalae, poria cocos, radix ophiopogonis, schisandra chinensis, hairyvein agrimony, perilla seeds, cortex moriradicis, folium eriobotryae, radix platycodi, apricot kernels, and radix glycyrrhizae. According to the monarch, minister, assistant and guide theory of traditional Chinese medicines, the radix codonopsis is used as a monarch drug; fried rhizoma atractylodis macrocephalae, the poria cocos, the radix ophiopogonis, the schisandra chinensis, and the hairyvein agrimony are used as minister drugs; the perilla seeds, the cortex moriradicis, and the folium eriobotryae are used as assistant drugs; and the radix platycodi, the apricot kernels, and the radix glycyrrhizae are used as guide drugs. Also disclosed is use of the traditional Chinese medicine ...

CRUDE DRUG COMPOSITION FOR PREVENTING OR TREATING RESPIRATORY DISEASES

The present disclosure relates to a pharmaceutical composition for preventing or treating respiratory diseases and a food composition for preventing or relieving respiratory diseases comprising as an active ingredient two or more mixed extracts selected from the group consisting of a Brassicae Semen extract, an Adenophorae Radix extract, a Lonicerae Folium extract and a Perillae Semen extract. A composition comprising mixed extracts of Brassicae Semen, Adenophorae Radix, Lonicerae Folium and Perillae Semen of the present disclosure has an advantage of preventing respiratory diseases and relieving the symptoms of respiratory diseases, restores damages in the lung tissue, inhibits aging action and inflammation induced by inflammation-inducing substances such as fine dust, and has an excellent antioxidant effect. More particularly, the composition of the present disclosure increases the expression of a telomerase which extends the length of a telomere, and thus is expected to fundamentally ...

ACTIVE INGREDIENT COMBINATIONS OF PLANT OILS CONTAINING OMEGA-3 FATTY ACIDS AND PLANT EXTRACTS CONTAINING ISOPRENOIDS AND THE USE THEREOF

The invention relates to active ingredient combinations of plant oils containing 3-fatty acids and plant extracts containing isoprenoids with improved tolerance and the use thereof for reducing an elevated blood cholesterol level, for the prevention or treatment of an artherosclerosis or coronary heart disease and for the prevention or treatment of a disease related to a sex hormone.

ТРАДИЦИОННЫЕ КИТАЙСКИЕ ЛЕКАРСТВЕННЫЕ ПРЕПАРАТЫ ДЛЯ ЛЕЧЕНИЯ ДЕПРЕССИИ, ИХ СОСТАВ, СПОСОБ ПРИГОТОВЛЕНИЯ И ЛЕЧЕНИЯ

Изобретение относится к фармацевтической промышленности, в частности к средствам для лечения депрессии. Традиционное китайское лекарственное средство для лечения депрессии. Способ приготовления традиционного китайского лекарственного средства для лечения депрессии. Продукт. Фармацевтический состав для лечения депрессии. Способ приготовления фармацевтического состава (варианты). Применение традиционного китайского лекарственного средства в производстве лекарств для лечения депрессии. Применение продукта для производства препарата для лечения депрессии. Способ лечения депрессии (варианты). Вышеописанные средства эффективны для лечения депрессии. 11 н. и 10 з.п. ф-лы, 14 табл.

USE OF THE FRUITS OF A PLANT OF THE KIND OCIMUM FOR THE PRODUCTION OF A PREPARATION APPROXIMATELY FETTLEIBIGHEIT.

USE OMEGA-3-FETTSÄUREHALTIGER OF OILS FOR THE INCREASE OF THE BIO-AVAILABILITY OF PLANT EXTRACTS

Plant derived seed extract rich in essential fatty acids derived from perilla seed: composition of matter, manufacturing process and use

A composition of matter comprises a shelf stable, super critical, CO2 fluid extracted seed oil derived from a cracked biomass of perilla frutescens, the seed oil comprising from about 60 to about 95 percent w/w of PUFAs in a ratio of from about 4:1 to about 6:1 alpha-linolenic acid (ALA) to linoleic acid (LA) and a mixture of selected antioxidants.

Methods and compositions for treating skin to resolve inflammation and screening for actives that stimulate pro-resolution pathways

Compositions and methods for treating inflamed skin with Pro-Resolution Pathway Stimulators that may be Inflammatory Metabolite Inhibitors, Pro-Resolving Activators, or combinations thereof, and a method for screening active ingredients for activity as Pro-Resolution Pathway Stimulators for incorporation into topical cosmetic products.

LTBP-1 expression promoting composition and method for screening for substance having LTBP-1 expression promoting function

The purpose of the present invention is to provide a LTBP-1 expression promoting composition that promotes LTBP-1 expression and a method for screening for a substance having a LTBP-1 expression promoting function, etc. The present invention relates to a LTBP-1 expression promoting composition, including an extract of one or more plants selected from the group consisting of rose, jiaogulan, Roberts geranium, calamus, beefsteak plant, sage, and star fruit. The rose contains a rosacyanine compound and/or a rosadelphin compound.

PHARMACEUTICAL COMPOSITION COMPRISING EDIBLE ACIDS OR THE ACID SALTS AND ITS USE

The invention relates to pharmaceutical compositions for treatment or amelioration of immunity disease through reducing PH of body fluid. Uses of edible acid and/or acid salt, or fruits comprising edible and/or acid salt or their products, in preparation of food, drink or health care products, for improving individual immunity; preparation of food for reducing risk of hypersensitive response. Medical preparation in the use of prevention or treatment of cold, insect biting, dermatitis, or in the use of glove-treating agent, transdermal agent.

METHODS AND COMPOSITIONS FOR TREATING SKIN TO RESOLVE INFLAMMATION AND SCREENING FOR ACTIVES THAT STIMULATE PRO-RESOLUTION PATHWAYS

Compositions and methods for treating inflamed skin with Pro-Resolution Pathway Stimulators that may be Inflammatory Metabolite Inhibitors, Pro-Resolving Activators, or combinations thereof, and a method for screening active ingredients for activity as Pro-Resolution Pathway Stimulators for incorporation into topical cosmetic products.

Method for overlap pressing of traditional Chinese medicinal tablets or traditional Chinese medicinal materials

The invention provides a method for overlap pressing of traditional Chinese medicinal tablets or traditional Chinese medicinal materials, and also provides a pressing mold for the traditional Chinese medicinal materials and the traditional Chinese medicinal tablets. According to the method for overlap pressing of the traditional Chinese medicinal tablets or the traditional Chinese medicinal materials, each traditional Chinese medicinal tablet or traditional Chinese medicinal material discharged from a lower end and pressed to form is pressed for same times so as to avoid the difference of the quality of finished products due to uneven pressure between an upper pressing product and a lower pressing product, the dimensional stability of a pressing molding product is obviously increased, and the traditional Chinese medicinal tablet or the traditional Chinese medicinal material can be conveniently stored, transported and used. Additionally, the pressing time is effectively saved, and the cost ...

Postpartum uterine contraction pain treating drug and preparation method thereof

Traditional Chinese medicine composition for treating allergic dermatitis

The invention provides a traditional Chinese medicinal composition for treating relapsing allergic dermatitis, wherein fruit of common perilla, peppermint, chrysanthemum and purslane herb are sued as raw medicinal materials and are prepared into orally administrated preparations and externally applied preparations with auxiliary materials according to a conventional process of pharmaceutics. Proved by clinical researches, the medicinal composition has favorable effects of relieving, repairing, allergy resistance, desensitization, skin nourishment and beauty maintain on acute and chronic relapsing allergic dermatitis. Therefore, the medicinal composition can be prepared into various orally administrated preparations and externally applied preparations by adopting the conventional process of the pharmacy of Chinese medicinal herbs; the traditional Chinese medicinal composition can also be used as an active component to produce various skin care products according to the conventional process ...

Health restoring agastache dripping pill preparation and its preparing method

Traditional Chinese medicinal recipe for inhibiting Edwardsiella tarda

Drug for empyrosis and scald, and its preparing method

Extraction and identification of perilla flavonoid compound

Process of stabilization of derived from amides of higher fatty-acids

PHARMACEUTICAL COMPOSITION COMPRISING LUTEOLIN-7-O-DIGLUCURONIDE, APIGENIN-7-O-DIGLUCURONID ISOLATED FROM PERILLA FRUTESCENS VAR. ACUTA LEAF EXTRACT FOR IMPROVING OCULAR FATIGUE

A DRUG FOR TREATING COLD AND ITS PREPARATION METHOD

ANTIVIRAL AGENT AND ANTITUMOR AGENT

PURPOSE: Provided are antiviral and antitumor agents which have an inhibiting effect on retrovirus and destroy malignant tumor(cancer) without causing any side effects. And their preparation is also provided. CONSTITUTION: The antiviral and antitumor agents comprise unsaturated fatty acid extract of sesame and alkaline extract of Acanthopanax sessiliflorum Semen. The unsaturated fatty acids are extracted from sesame by compressing without heating to produce an unsaturated fatty acids extract. An extract of Acanthopanax sessiliflorum Semen is obtained by dipping the Acanthopanax sessiliflorum Semen into hot water and then filtering the water through a sanitary cotton to produce an alkaline extract. The amount of water used for such extraction should be about 5 to 1000 times as much as the weight of Acanthopanax sessiliflorum Semen. The unsaturated fatty acid extract of sesame and the alkaline extract of Acanthopanax sessiliflorum Semen are mixed in a mixing ratio of about 1 to 1-5. The mixed ...

COMPOSITION FOR IMPROVING IMMUNE ACTIVITY CONTAINING LACTOBACILLUS

COMPOSITION FOR PREVENTING HAIR LOSS AND STIMULATING HAIR GROWTH COMPRISING COMBINED EXTRACT CONSISTING OF HEAT-PROCESSED GINSENG, HOUTTUYNIAE HERBA, PERILLA LEAF AND GREEN TEA LEAVES AS ACTIVE INGREDIENT

The present invention relates to a composition containing an extract of combined medicinal herbs consisting of heat-treated ginseng, Houttuyniae herba, perilla leaf and green tea leaves, or a processed extract thereof as active ingredients for preventing hair loss and stimulating hair growth. Through various animal model experiments such as an experiment to measure a hair-growing effect using 6-week old male C57BL/6 mice (Experimental Example 1); and an experiment to measure an activating effect on the differentiation and proliferation of hair follicle dermal papilla cells (HFDPC) (Experimental Example 2), it was confirmed that the processed combined extract of the present invention showed far more potent hair-growth promoting effects than the fermented extract of Houttuyniae herba, perilla leaf and green tea leaf disclosed in the prior art document (Korean Patent Publication No. 10-2014-0114492). Therefore, the composition of the present invention can be beneficially used for treating ...

Composition comprising an extract of Perilla frutescens leaves showing antibacterial actibity

PURPOSE: An antibacterial composition containing sesame leaf extract is provided to suppress pathogenic bacteria and to ensure excellent antibacterial activity. CONSTITUTION: An antibacterial composition contains sesame leaf extract as an active ingredient. The sesame leaf extract is isolated using distilled water as a solvent. An hot water extract of sesame leaf is obtained by isolating at 60°C-100°C for 20 minutes to two hours in 10-30 times weight of distilled water. The antibacterial composition has an antibacterial activity against Salmonella typhimurium, Staphylococcus aureus, Listeria monocytogenes, Psendomonas aeruginosa, or Klebsilla pneumoniae. An antibacterial pharmaceutical composition, cosmetic composition, or disinfection composition contains the sesame extract as an active ingredient. COPYRIGHT KIPO 2011 ...

LTBP-1 EXPRESSION PROMOTING COMPOSITION AND METHOD FOR SCREENING FOR SUBSTANCE HAVING LTBP-1 EXPRESSION PROMOTING FUNCTION

The purpose of the present invention is to provide a LTBP-1 expression promoting composition that promotes LTBP-1 expression and a method for screening for a substance having a LTBP-1 expression promoting function, etc. The present invention relates to a LTBP-1 expression promoting composition, including an extract of one or more plants selected from the group consisting of rose, jiaogulan, Roberts geranium, calamus, beefsteak plant, sage, and star fruit. The rose contains a rosacyanine compound and/or a rosadelphin compound.

THE COMPOSITION OF TCM FOR TREATING DEPRESSION, FORMULATIONS CONTAINING THE SAME, PROCESS FOR PREPARATION AND USE THEREOF

The composition of Traditional Chinese Medicine (TCM) for treatment of depression, comprising as active ingredients Fructus gardeniae, Fructus forsythiae, Rhizoma pinelliae, and Cortex magnoliae; the process for preparation of the composition of TCM and the mixture of TCM prepared by the process; the pharmaceutical formulations containing said mixture of TCM or said composition of TCM of the present invention and the process for preparation thereof; the use of the composition of TCM of the present invention in manufacture of medicaments for treating depression.

PHARMACEUTICAL COMPOSITION FOR USE PREVENTING AND CURING RESPIRATORY DISEASES IN WINTER

The present invention relates to a pharmaceutical composition for use preventing and curing respiratory diseases in winter. The composition comprises burdock seeds, blackberry lily, Platycodon grandiflorus, radix paeoniae rubra, Perilla frutescens, honeysuckle, fructus crataegi, Astragalus membranaceus, Reynoutria japonica, Glycyrrhiza uralensis, and non-essential fermented tea. The present invention also relates to a pharmaceutical preparation use of the pharmaceutical composition. The pharmaceutical composition can be used for nourishing Qi, moistening lungs, clearing throats, relieving sore throats and/or decontaminating, and can be used for preparing a pharmaceutical for treating and/or preventing pharyngitis.

Nasal composition

The present invention relates to a nasal composition comprising an anti-allergic oil derived from plant; and an oil-based barrier-forming preparation. The composition may be used in preventing and/or treating allergic disorders of the nasal cavity, including seasonal allergic rhinitis (hay fever) and perennial allergic rhinitis.

ТРАДИЦИОННАЯ КИТАЙСКАЯ ЛЕКАРСТВЕННАЯ КОМПОЗИЦИЯ ДЛЯ ЛЕЧЕНИЯ БРОНХИАЛЬНОЙ АСТМЫ И СПОСОБ ЕЕ ПРИГОТОВЛЕНИЯ

Настоящее изобретение относится к композиции традиционного китайского лекарственного средства для лечения бронхиальной астмы и способу ее приготовления. Традиционная китайская лекарственная композиция готовится из чистых растительных сырьевых лекарственных средств, включающих траву эфедры (Herba Ephedrae), семена гингко (Semen Ginkgo), кору шелковицы (Cortex Mori), корень шлемника (Radix Scutellariae), семена абрикоса горького (Semen Armeniacae Amarum), корневище пинеллии (Rhizoma Pinelliae), плоды периллы (Fructus Perillae), цветки мать-и-мачехи (Flos Farfarae), корень пиона красного (Radix Paeoniae Rubra), траву гуттуинии (Herba Houttuyniae), корень трихозана (Radix Trichosanthis), плоды форзиции (Fructus Forsythiae). Традиционная китайская лекарственная композиция эффективна при лечении бронхиальной астмы. 2 н. и 9 з.п. ф-лы, 7 табл., 12 пр.

Zusammensetzungen enthaltend omega-3-fettsäurehaltige Öle und Pflanzenextrakte

Die vorliegende Erfindung betrifft Zusammensetzungen, die omega-3-fettsäurehaltige Öle und Pflanzenextrakte enthalten, und deren Verwendung als diätetisches Nahrungsmittel oder Arzneimittel bzw. pharmazeutische Zubereitung mit erhöhter Bioverfügbarkeit der in den Zubereitungen enthaltenen sekundären Pflanzeninhaltsstoffe.

ÄTHERISCHES ÖL BEINHALTENDE ZUBEREITUNG

Unit dose packages, compositions, and treatment regimens to deliver pro-resolution pathway stimulators to keratin surfaces

A unit dose package containing a composition comprising at least one Pro-Resolution Pathway Stimulator is provided. The unit dose package may be a capsule, preferably an ampoule, or a facial treatment mask. The Pro-Resolution Pathway Stimulator may comprise an Inflammatory Metabolite Inhibitor, a Pro-Resolving Activator, a mixture of an Inflammatory Metabolite Inhibitor and a Pro-Resolving Activator, or both an Inflammatory Metabolite Inhibitor and a Pro-Resolving Activator. Preferably the Pro-Resolving stimulator comprises a Pro-Resolving Activator that stimulates an increase in cellular concentration of Pro-Resolution lipid mediators, in particular Resolvin, Protectin, Lipoxin and Maresin. Preferably the pro-resolution pathway stimulators are selected from omega-3/omega-6 fatty acids, salicylic acid, resveratrol, resveratrol salicylate, Perilla ocymoides seed oil, Camellia japonica extract, Poria cocos extract, Aleurites moluccana (Kukui) seed oil, Camelina sativa seed oil, Dongbaek ( ...

Chinese Herbal Medicine Bait for Improving Disease Resistance Immunity of Grass Carp

Chinese herbal medicine bait for improving disease resistance immunity of grass carp comprises: Coptis chinensis, rhubarb, Scutellaria baicalensis Georgi, Isatis tinctoria, Forsythia suspensa, Perillafrutescens, Acorus tatarinowii, nutgall, ginger, garlic, and powder mixture. Grass carp feed formula is: wheat middlings, imported fish meal, beer yeast powder, wheat bran, rice bran meal, 46% soybean meal, rapeseed meal, stone powder, soybean oil, salt, calcium hydrogen phosphate, MZ, phytase, complex enzyme, choline, 98.5% lysine, 99% threonine, VC, VE, antioxidant and mildew inhibitor. Add the Chinese herbal medicines into the feed in proportion of 1%-1.5%. Then make the feed into medicine bait particles with different particle sizes. The bait does not pollute the environment and is not enriched in fish. It facilitates the prevention and treatment of large-scale fish diseases, reduces the mortality and increases growth rate.

COMPOSITIONS FOR PREVENTING OR TREATING POLLENOSIS, ALLERGIC NEPHRITIS, ATOPIC DERMATITITS, ASTHMA OR URTICARIA

Plant derived seed extract rich in essential fatty acids derived from perilla seed: composition of matter, manufacturing process and use

A composition of matter comprises a shelf stable, super critical, CO2 fluid extracted seed oil derived from a cracked biomass of perilla frutescens, the seed oil comprising from about 60 to about 95 percent w/w of PUFAs in a ratio of from about 4:1 to about 6:1 alpha-linolenic acid (ALA) to linoleic acid (LA) and a mixture of selected antioxidants.

ACTIVE INGREDIENT COMBINATIONS OF PLANT OILS CONTAINING .OMEGA.3-FATTY ACIDS AND PLANT EXTRACTS CONTAINING POLYPHENOLS AND THE USE THEREOF

The invention relates to active ingredient combinations of oils containing .omega.3-fatty acids and plant extracts containing polyphenols and the use thereof for the treatment of inflammatory and/or immunological and metabolic diseases and other ailments.

COMPOSITIONS FOR PREVENTING OR TREATING POLLENOSIS, ALLERGIC NEPHRITIS, ATOPIC DERMATITITS, ASTHMA OR URTICARIA

Compositions for treating pollinosis, allergic nephritis, atopic dermatitis, asthma or urticaria, health foods or functional foods which contain two crude drugs of pumpkin seeds and safflower together with at least one crude drug selected from among Plantago asiatica L., Louicera japonica Thunberg, Glycyrrhizae Radix, Coix lacryma-jobi Linne var. ma-yuen, Zingiberis Rhizoma, Turmeric, Zedoary and Artemisiae Argyi Forium as the active ingredients.

COMBINATION OF AN ANTIALLERGIC AGENT WITH MUSCARINIC ANTAGONIST AND/OR DOPAMINERGIC AGONIST FOR USE IN PREVENTING/STOPPING OF AXIAL MYOPIA IN HUMAN

One of the major issues against the use of muscarinic antagonists or dopamine agonist eyedrops for the controlling of eye growth and prevention of myopia is the unacceptable rate of iatrogenic conjunctivitis or dermatitis. This invention relates to the association of those active principles with an antiallergic component. In alternative the ophthalmic use of a molecule that simultaneously has an antimuscarinic and/or dopaminergic action along with an antihistaminic function.

Plant derived seed extract rich in essential fatty acids derived from perilla seed: composition of matter, manufacturing process and use

A composition of matter comprises a shelf stable, super critical, CO2 fluid extracted seed oil derived from a cracked biomass of perilla frutescens, the seed oil comprising from about 60 to about 95 percent w/w of PUFAs in a ratio of from about 4:1 to about 6:1 alpha-linolenic acid (ALA) to linoleic acid (LA) and a mixture of selected antioxidants.

External prescription for treating erysipelas on lower limbs

Prescription of specific medicine for treating common cold and enteric fever

People in the countryside often suffer from strain typhia caused by excessive strain and people suffering from the strain typhia have the symptoms of high fever, feeling cold, general weakness, bedrid and continuous groaning. In daily life, bad cold can cause a fever. The invention provides a preparation of specific medicine for cold and typhia, which has the components of 4.5-9 g of perilla, 9-30 g of Millettia and 9-15 g of Rhynchosia and is prepared by decocting the components with soft fire and is taken two times one day. According to the operation and the use, the invention can achieve the purposes of treating the cold and the typhia with quick effect, short time and low cost.

Medicine used for treating nasosinusitis

Cell wall broken Ganoderma Lucidum spore powder-Perilla herb oil composite softgel and preparation technology thereof

The invention discloses a cell wall broken Ganoderma Lucidum spore powder-Perilla herb oil composite softgel and a preparation technology thereof. The preparation technology comprises the following steps: 1, sieving Ganoderma Lucidum spore powder by a 20 mesh sieve, elutriating, separating, and drying at 60DEG C to obtain dried Ganoderma Lucidum spore powder for later use; 2, carrying out wall breaking of the dried Ganoderma Lucidum spore powder by adopting a roller type wall breaker, stopping the wall breaking when the wall breaking rate detected by a blood counting chamber reaches 90-97%, and carrying out sealing preservation of the cell wall broken Ganoderma Lucidum spore powder in 0-5DEG C environment to obtain cell wall broken Ganoderma Lucidum spore powder; 3, mixing the cell wall broken Ganoderma Lucidum spore powder with an oil agent composed of Perilla herb oil and vitamin E, carrying out mechanical stirring beating, carrying out colloid mill treatment to obtain a mixed slurry, ...

INDUCTORS Of INTERFERON AND THEIR MANUFACTORING PROCESS

L'invention concerne l'industrie pharmaceutique. Elle concerne une substance présentant une activité inductrice d'interféron, d'un poids moléculaire d'environ 100 000 à 3000000, contenant comme constituants principaux des amino-acides, des sucres et de l'acide phosphorique, présentant une activité effective envers divers virus, ladite substance étant produite par extraction du tissu d'une plante appartenant au genre Perilla de la famille Labiatae, ou d'une de ses variantes, l'extraction étant effectuée de préférence avec de l'eau et la récupération dans l'extrait étant effectuée par ultracentrifugation. Application comme médicament pour la prévention et le traitement de diverses maladies virales. The invention relates to the pharmaceutical industry. It relates to a substance exhibiting interferon inducing activity, with a molecular weight of about 100,000 to 3,000,000, containing as main constituents amino acids, sugars and phosphoric acid, exhibiting effective activity against various viruses. , said substance being produced by extracting tissue from a plant belonging to the genus Perilla of the family Labiatae, or one of its variants, the extraction preferably being carried out with water and the recovery in the extract being performed by ultracentrifugation. Application as a medicament for the prevention and treatment of various viral diseases.

ANTICANCER AGENT CONTAINING PERILLA OIL AS EFFECTIVE COMPONENT

PURPOSE: An anticancer agent containing perilla oil as an effective ingredient is provided, which has a significant anticancer effect on human and inhibits coagulation of a thrombocyte and formation of a thrombus. CONSTITUTION: This anticancer agent contains perilla oil containing a large amount of α-LNA as the parent of ω-3 based fatty acid as an effective ingredient. The agent has an effect on strengthening a cerebral nerve system function, inhibiting an allergic reaction and shows an anticancer effect. COPYRIGHT 2001 KIPO ...

인간에서 축성 근시를 예방/중단하는데 사용하기 위한 무스카린성 길항제 및/또는 도파민성 작용제를 갖는 항알레르기제의 배합물

... 눈 성장의 조절 (controlling of eye growth) 및 근시 (myopia) 예방을 위한 무스카린성 길항제 (muscarinic antagonist) 또는 도파민 작용제 (dopamine agonist) 점안액 (eyedrop)의 사용에 대한 한가지 주요한 이슈는, 용인할 수 없는 속도의 의원성 결막염 (iatrogenic conjunctivitis) 또는 피부염이다. 본 발명은 항알레르기성 성분을 갖는 이들의 활성 성분의 회합 (association)에 관한 것이다. 대안으로, 항히스타민성 기능과 함께 항무스카린성 및/또는 도파민작용성 작용을 동시에 갖는 분자의 안과적 사용에 관한 것이다.

ANTIVIRAL AND ANTICANCER AGENT

PURPOSE: Provided is an antiviral and anticancer agent having unsaturated fatty acid of sesame and alkaline synthetic extract of E. Pedunculus as an effective ingredient. The agent inhibits not only the replication and the infection of retrovirus, but also malignant tumor. CONSTITUTION: An antiviral and anticancer agent is prepared by the following steps of: (a) washing sesames, drying water of 15% therefrom and compressing them without heating; (b) washing E. Pedunculus and drying it; and (c) extracting the E. Pedunculus with warm water and filtering it, to obtain unsaturated fatty acid extract such as protein, amino acid, methionine, substrate and calcium, and alkaline synthetic extract of E. Pedunculus such as sterol, ditrepene and lignan. COPYRIGHT 2001 KIPO ...

COMPOSITION FOR IMPROVING COGNITIVE ABILITY OR MEMORY ABILITY, CONTAINING FERMENTED PERILLA FRUTESCENS EXTRACT, AND USE THEREOF

The present invention relates to a composition, a fiber or a fragrance composition for improving cognitive ability or memory ability, containing a fermented Perilla frutescens extract. In addition, the present invention relates to a composition for preventing, alleviating or treating cognitive ability- or memory ability-related diseases, containing a fermented Perilla frutescens extract. Furthermore, the present invention relates to a method for treating cognitive ability- or memory ability-related diseases, comprising a step of administering a fermented Perilla frutescens extract to a patient with a cognitive ability- or memory ability-related disease. Compared to an unfermented Perilla frutescens extract, a fermented Perilla frutescens extract of the present invention significantly increases cognitive ability or memory ability, thereby being effectively usable as a composition for improving cognitive ability or memory ability. Moreover, a fermented Perilla frutescens extract of the present ...

COMPOSITIONS AND APPLICATIONS WITH FUNCTIONS TO IMPROVE THE DIVERSITY OF PERSONALIZED INTESTINAL FLORA

Provided is a composition functioning to improve personalized gut microbiota diversity function. The composition includes ingredients for strengthening spleen and invigorating Qi, ingredients for clearing damp and promoting the circulation of blood, and intestinal bacteria substrates. The ingredients for strengthening spleen and invigorating Qi include one or more of Panax ginseng, an extract of Panax ginseng, Panax quiquefolium, and an extract of Panax quiquefolium; the ingredients for clearing damp and promoting the circulation of blood include an ingredient for clearing damp and an ingredient for promoting the circulation of blood, where the ingredient for clearing damp includes one of or a mixture of more of Wolfiporia cocos and an extract of Wolfiporia cocos, and the ingredient for promoting the circulation of blood includes one of or a mixture of more of nattokinase, natto, and an extract of natto; the intestinal bacteria substrates include water-soluble dietary fiber, water-insoluble ...

КОМПОЗИЦИИ ДЛЯ ПРОФИЛАКТИКИ ИЛИ ЛЕЧЕНИЯ ПОЛЛИНОЗА, АЛЛЕРГИЧЕСКОГО НЕФРИТА, АТОПИЧЕСКОГО ДЕРМАТИТА, АСТМЫ ИЛИ КРАПИВНИЦЫ

Изобретение относится к фармацевтической промышленности, в частности к созданию композиции для профилактики или лечения поллиноза, аллергического ринита, атопического дерматита, астмы или крапивницы. Композиция для профилактики или лечения поллиноза, аллергического ринита, атопического дерматита, астмы или крапивницы, содержащая два вида лекарственного сырья из семян Cucurbita moschata и из Carthamus tinctorius и по меньшей мере одно лекарственное сырье, выбранное из Plantago asiatica, Lonicera japonica, Coix lachrymal-jobi var. ma-yuen. Композиция для профилактики или лечения поллиноза, которая используется для введения млекопитающему, страдающему поллинозом, ежегодно перед сезоном поллиноза; содержащая два вида лекарственного сырья из семян Cucurbita moschata, из Carthamus tinctorius и по меньшей мере одно лекарственное сырье, выбранное из Plantago asiatica, Lonicera japonica, Coix lachrymal-jobi var. ma-yuen, в качестве эффективного компонента. Способ получения композиции для профилактики ...

КОМПОЗИЦИИ ДЛЯ ПРОФИЛАКТИКИ ИЛИ ЛЕЧЕНИЯ ПОЛЛИНОЗА, АЛЛЕРГИЧЕСКОГО НЕФРИТА, АТОПИЧЕСКОГО ДЕРМАТИТА, АСТМЫ ИЛИ КРАПИВНИЦЫ

... 1. Профилактическая или терапевтическая композиция для профилактики или лечения поллиноза, аллергического ринита, атопического дерматита, астмы или крапивницы, содержащая два вида лекарственного сырья из семян Cucurbita moschata и из Carthamus tinctorius и по меньшей мере одно лекарственное сырье, выбранное из Plantago asiatica, Lonicera japonica, Glycyrrhiza uralensis, Coix lachrymal-jobi var. ma-yuen, Zingiber officinale, Curcuma longa, Curcuma zedoaria и Artemisia argyi. 2. Композиция по п.1, которая используется для профилактики или лечения аллергического ринита, астмы или крапивницы. 3. Профилактическая или терапевтическая композиция по п.1, которая содержит четыре вида лекарственного сырья из семян Cucurbita moschata, из Carthamus tinctorius, Plantago asiatica и Lonicera japonica в качестве эффективного компонента. 4. Профилактическая или терапевтическая композиция для профилактики или лечения поллиноза, которая используется для введения млекопитающему, страдающему поллинозом, ежегодно ...

Interferon inducers, processes for their preparation, pharmaceutical compositions containing them and their use as medicaments.

An interferon inducer isolated from the plant tissue, having an elemental analysis of H: 8.5-8.7%, C: 48.8-49%, N: 6.3-6.5% and P: 1.0-1.1% and a molecular weight of from about 100,000 to about 3,000,000 (mainly about 200,000 to about 1,000,000) and containing as main constituents amino acids, sugars and phosphoric acid. This substance is believed to be a homogeneous polymer of protein and sugars, containing phosphoric acid. This substance has an excellent interferon inducing activity and low toxicity and is significantly active against various viruses. The interferon inducer may be produced by extracting a substance having interferon inducing activity from the tissue of a plant of the genus Perilla of the family Labiatae or a variant thereof containing said active substance and recovering the active substance from the extract thereby obtained. Preferably, the extraction may be effected with water and the recovery may be effected by ultrafiltration. Pharmaceutical composition of this invention ...

Medicinal diet product composition for hyperlipemia and fatty liver and preparation method thereof

This invention provides medicinal diet product composition for hyperlipemia and fatty liver and preparation method thereof, which comprises the following components in part by weight: 1-15 parts of Hippophae rhamnoides , 1-20 parts of Moringa oleifera Lam., 1-15 parts of Cichorium intybus L., 1-20 parts of Phyllanthus emblica Linn, 1-20 parts of Portulaca oleracea L, 1-20 parts of Semen Cassiae, 1-15 parts of Pueraria lobata, 1-15 parts of Perillafrutescens, 1-20 parts of Cannabis sativa seed,1-16 parts of thallus laminariae, 1-15 parts of lotus leaf, 0.1-3 parts of chitosan oligosaccharide, 0.5-5 parts of xylooligosaccharide, and the method of preparing the medicinal diet product composition for hyperlipemia and fatty liver. The medicinal diet product composition for hyperlipemia and fatty liver has the characteristics of clear curative effect, clear action target and pharmacological effect, wide source of raw materials, low cost, simple preparation method, high patient compliance and ...

Traditional Chinese medicinal composition for treating bronchial asthma and preparation method thereof

Fine processing method of folium perillae

A hold pillow for improving hand joint is stiff damaged with skin

Medicine for relieving asthma and cough and its preparing method

The present invention relates to a kind of medicine for relieving asthma and cough and its preparation process. The medicine of the present invention has Chinese ephedra as chief medicine component, perilla leaf and bupleurum root as adjuvant medicine component, almond, dried orange peel and magnolia bark as assistant medicine components and roasted licorice as guide medicine component. The medicine has determined clinical treating effect, and the functions of promoting lung-Qi flow, relieving asthma, regulating Qi and relieving cough. The medicine may be used in treating cough and asthma caused by wind-cold as well as bronchial asthma and bronchitis.

Health-care cigarette

Traditional Chinese medicine composition for treating sheep endoparasites and preparation method and application thereof

Milk of perilla seed oil

Health product for enhancing immunity, protecting liver, lowering enzyme and resisting chemical hepatic injury

Powder comprising mint and chrysanthemum

COMPOSITION AND METHOD TO ALLEVIATE JOINT PAIN USING PHOSPHOLIPIDS AND ASTAXANTHIN

A dietary supplement composition and associated method of use has the composition formulated in a therapeutic amount to treat and alleviate symptoms of joint pain in a person having joint pain. The composition includes astaxanthin and microbial fermented, low molecular weight hyaluronic acid or sodium hyaluronate (hyaluronan). The composition also includes at least one of a phospholipid, glycolipid, and sphingolipid. It is formulated into an oral dosage form and the astaxanthin is 0.1 to 15 percent by weight of the at least one phospholipid, glycolipid, and sphingolipid. 1. A method to treat and alleviate symptoms of joint pain by administering to a person having joint pain a therapeutic amount of a dietary supplement composition , including astaxanthin , pro-inflammatory low molecular weight microbial fermented sodium hyaluronate fragments having a molecular weight of 0.5 to 300 kilodaltons (kDa) , and a marine or seed oil and including a lipid selected from the group consisting of a phospholipid , glycolipid , and sphingolipid , and formulated into an oral dosage form , wherein the astaxanthin is 0.1 to 15 percent by weight of the marine or seed oil and the lipid selected from the group consisting of the phospholipid , glycolipid and sphingolipid.2. The method according to claim 1 , wherein the astaxanthin comprises a natural or synthetic ester or synthetic diol derivative.3. The method according to claim 1 , further comprising adding a pharmaceutical or food grade diluent to the marine or seed oil and the lipid selected from the group consisting of the phospholipid claim 1 , glycolipid and sphingolipid.4. The method according to claim 1 , wherein the phospholipid is selected from the group consisting of Phosphatidylcholine claim 1 , Phosphatidylethanolamine claim 1 , Phosphatidylserine claim 1 , Phosphatidylinositol claim 1 , Phosphatidic acid claim 1 , Lyso-Phosphatidylcholine claim 1 , Lyso-Phosphatidylethanolamine claim 1 , and Lyso-Phosphatidylserine.5. The ...

METHOD FOR PRODUCING RED PERILLA LEAF EXTRACT

Provided is a method for producing a red leaf extract which enables to collect rosmarinic acid with a high yield from red leaves to which an acid is added. The method for producing a red leaf extract includes the following step (1): (1) a step of extracting red leaves to which an acid has been added with water under a condition of a pH of from 4.0 to 8.0. 1perilla. A method for producing a red leaf extract , the method comprising:{'i': 'perilla', '(1) extracting red leaves to which an acid has been added with water under a condition of a pH of from 4.0 to 8.0.'}2perilla. A method for producing a purified red leaf extract , the method comprising:{'i': 'perilla', '(1) extracting red leaves to which an acid has been added with water under a condition of a pH of from 4.0 to 8.0 to form an extract solution;'}(2) concentrating the extract solution obtained in the extracting (1) to form a concentrated extract solution; and(3) adding ethanol or an ethanol aqueous solution to the concentrated extract solution obtained in the concentrating (2) and then removing a precipitate.3. The producing method according to claim 1 , wherein an extraction temperature in the extracting (1) is 50° C. or more.4. The producing method according to claim 2 , wherein claim 2 , in the step-extracting (1) claim 2 , a bath ratio of water is from 4 to 35 (L/kg).5. The producing method according to claim 2 , wherein claim 2 , in the step adding (3) claim 2 , ethanol or an ethanol aqueous solution is added to the concentrated extract solution such that an ethanol concentration is from 40 to 95 vol %.6. The producing method according to claim 2 , wherein claim 2 , in the concentrating (2) claim 2 , the pH of the extract solution obtained in the extracting (1) is further optionally adjusted to a pH of from 4.0 to 7.5 before the concentrating or the pH of the concentrated extract solution is further optionally adjusted to a pH of from 4.0 to 7.5 after the concentrating.7. The producing method according ...

METHOD AGAINST CORONAVIRUS INFECTION WITH WATER-EXTRACTED PRODUCT OF PERILLA FRUTESCENS

Disclosed herein is a method against coronavirus infection, which includes administering to a subject in need thereof a composition containing a water-extracted product of 1Perilla frutescens.. A method against coronavirus infection , comprising administering to a subject in need thereof a composition containing a water-extracted product of2. The method according to claim 1 , wherein the coronavirus infection is caused by a coronavirus selected from the group consisting of severe acute respiratory syndrome coronavirus (SARS-CoV) claim 1 , severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) claim 1 , middle east respiratory syndrome coronavirus (MERS-CoV) claim 1 , human coronavirus 229E (HcoV-229E) claim 1 , and combinations thereof.3. The method according to claim 1 , wherein the composition is a pharmaceutical composition.4. The method according to claim 3 , wherein the pharmaceutical composition is in a dosage form for oral administration.5. The method according to claim 3 , wherein the pharmaceutical composition is in a dosage form for parenteral administration. This application claims priority to Taiwanese Invention Patent Application No. 109132586, filed on Sep. 21, 2020.The present disclosure relates to a method against coronavirus infection with a composition containing a water-extracted product of(L.) Britt., commonly known as or wild sesame seed, is a species of in the mint family Lamiaceae. is an important economic crop and with a long cultivation history in China as well as some other countries in Asia. Except for the edible applications, the plant of has been also traditionally used as a medicinal herb in China for thousands years. The leaves, seeds, and stems of are recommended by the Chinese Pharmacopeia as three medicinal materials for various therapeutic applications. has been used as an important traditional herbal medicine for treating various diseases/disorders including depression, anxiety, tumors, asthma, cough, allergy, intoxication, ...

NANOPARTICLE OPHTHALMIC COMPOSITION FOR THE TREATMENT OF OCULAR DISORDERS OR DISEASES

Is herein described a nanoparticle ophthalmic composition comprising at least 0.1% of extract and at least 0.1% of hyaluronic acid or a salt thereof wherein the extract has a content of polyphenols of at least 2.5% by weight of the total weight of the extract and to the use of said ophthalmic composition in the treatment of ocular disorders or diseases such as tear dysfunction syndrome, dry eye, diabetic retinopathy and glaucoma, preferably in the treatment of tear dysfunction syndrome. 2) A nanoparticle ophthalmic composition according to wherein the ophthalmic composition is a sterile liquid formulation.3) A nanoparticle ophthalmic composition of claim 2 , wherein the sterile liquid formulation is selected from the group consisting of eye drops claim 2 , semi-solid formulations claim 2 , creams and gels.4) A nanoparticle ophthalmic composition according to wherein the sterile liquid formulation is in the form of eye drops.5Perilla frutescens) A nanoparticle ophthalmic composition according to containing from about 0.1% to about 5% by weight of a extract with respect to the total weight of the ophthalmic composition.6Perilla frutescens) A nanoparticle ophthalmic composition according to containing from about 0.1% to about 0.2% by weight by weight of a extract with respect to the total weight of the ophthalmic composition.7Perilla frutescens) A nanoparticle ophthalmic composition according to containing from about 0.10% to about 0.15% by weight of a extract with respect to the total weight of the ophthalmic composition.8) A nanoparticle ophthalmic composition according to containing from about 0.1% to about 0.5% by weight of hyaluronic acid or a salt thereof with respect of the total weight of the ophthalmic composition.9) A nanoparticle ophthalmic composition according to containing about 0.25% by weight of hyaluronic acid or a salt thereof with respect of the total weight of the ophthalmic composition.10) A nanoparticle ophthalmic composition according to wherein ...

PERILLA SEED COMPOSITION

A composition of matter comprises a shelf stable, partially defatted supercritical COfluid solvent extracted whole grain flour derived from a cracked biomass of the flour comprising minerals and 2 to 8 percent of native seed oil, 35 to 45 percent protein, and 35 to 45 percent fiber. 1perilla frutescens,. A method of treating cardiovascular disease in humans or animals by administering an effective amount of a dietary supplement , food or beverage that has added thereto a composition comprising a shelf stable , partially defatted supercritical CO2 fluid solvent extracted whole grain flour derived from a cracked biomass of the flour comprising minerals and 2 to 8 percent of native seed oil , 35 to 45 percent protein , and 35 to 45 percent fiber.2. The method according to claim 1 , and further comprising forming a beverage claim 1 , liquid concentrate claim 1 , or dried beverage pre-mixes to which the composition is added.3. The method according to claim 1 , and further comprising preparing liquid concentrates or dried pre-mixes including protein shakes claim 1 , fruit smoothies claim 1 , ready-to-drink beverages claim 1 , dry beverage pre-mixes claim 1 , frozen fruit concentrates claim 1 , aqueous alcoholic beverage pre-mixes claim 1 , concentrates or their dried pre-mixes claim 1 , vitamin claim 1 , carbohydrate and protein fortified meal replacement beverages claim 1 , drinkable dairy and non-dairy yogurts claim 1 , gravies and dry gravy pre-mixes claim 1 , and ready-to-drink and dried pre-mixed infant formulas.4. The method according to claim 1 , and further comprising thickening a resulting final beverage by adding one or more acidulants for adjusting the pH from between about 3 to about 6.5.5. The method according to claim 1 , wherein the flour contains about 2 to about 3 percent fructo-oligosaccharides.6. The method according to claim 1 , wherein the flour exhibits pH dependent thixotropic properties when mixed with water.7. The method according to claim 1 , ...

Agent for Preventing or Amelioriting Noctura

An agent for preventing or ameliorating nocturia, containing rosmarinic acid or a salt thereof as an active ingredient. 113.-. (canceled)14. A method of preventing or ameliorating nocturia , comprising administering or ingesting rosmarinic acid or a salt thereof to or by a subject.1516.-. (canceled)17. The method according to claim 14 , wherein the rosmarinic acid or the salt thereof is in an extract of a plant belonging to the Lamiaceae family containing rosmarinic acid or a salt thereof.18Perilla frutescensacuta. The method according to claim 17 , wherein the plant is Britton var. Kudo.19. The method according to claim 17 , wherein the ratio of rosmarinic acid or a salt thereof in the extract of the plant with respect to the extract solid content in terms of rosmarinic acid content is 0.1 mass % or more and 100 mass % or less.20. The method according to claim 14 , wherein the compound is administered to or ingested by a subject who wants or needs prevention claim 14 , amelioration claim 14 , or treatment of nocturia.21. The method according to claim 20 , wherein the age of the subject is 20 years old or older.22. The method according to claim 14 , wherein the amount of administration or intake of the rosmarinic acid or the salt thereof in terms of rosmarinic acid content for one (1) adult (body weight 60 kg) per one (1) day is 0.1 mg or more and 40 claim 14 ,000 mg or less.23. The method according to claim 14 , wherein the blending amount or the content of the rosmarinic acid or the salt thereof in terms of rosmarinic acid content is 0.01 mass % or more and 100 mass % or less.24. The method according to claim 14 , wherein the blending amount or the content of the rosmarinic acid or the salt thereof in terms of rosmarinic acid content is 0.001 mass % or more and 50 mass % or less.25. The method according to claim 14 , wherein the rosmarinic acid or the salt thereof is ingested or administered once a day or divisionally several times a day or during an arbitrary ...

Topical Compositions Comprising Fermented Extracts of Traditional Chinese Medicinal (TCM) Ingredients, and Methods of Making and Using Same

The present invention relates to topical compositions containing fermented extracts of Traditional Chinese Medicinal (TCM) ingredients for improving the appearance and skin condition of the user. The topical compositions of the present invention are tailored for different users of different skin compositions according to TCM principles. The fermented TCM extracts are characterized by reduced odor and/or color in comparison with unfermented TCM extracts and are therefore more suitable for use in cosmetic products. 1Rhodiola roseaPerilla frutescensPhellodendron amurenseFoeniculum vulgareSantalum albumHordeum distichonCitrus reticulata{'i': Rhodiola rosea', 'Perilla frutescens', 'Phellodendron amurense', 'Foeniculum vulgare', 'Santalum album', 'Hordeum distichon', 'Citrus reticulata, '(i) blending rhizome, fruit, bark, and seed, stem, seed, and peel to provide a blend of extracts;'}(ii) fermenting the blend of extracts with a microorganism, wherein the microorganism can be yeast cells, and culturing nutrients; or(iii) fermenting the blend of extracts with microorganisms, wherein said microorganisms can be yeast cells, in an aqueous environment in substantial absence of additional nutrients or low nutrient media to catabolically process the blend of extracts;(iv) monitoring the fermentation of (ii) or (iii) for signs of plateauing biological activity;(v) briefly raising the temperature to rupture the yeast cells to release yeast cell contents, or disrupting the yeast cells by sonication; and(vi) filtering to remove yeast cell debris and to recover the blend of fermented extracts, wherein the blend of fermented extract has reduced odor and/or color, wherein the blend of fermented extracts is in the form of a fine powder, and wherein the topical composition further comprises a cosmetically or pharmaceutically acceptable carrier.. A topical composition for restoring Yin-Yang balance of skin of a person with Yin-dominant or balanced-to-Yin skin, said composition comprising ...

THERAPEUTIC ASTAXANTHIN AND PHOSPHOLIPID ROE EXTRACT COMPOSITION AND ASSOCIATED METHOD

A dietary supplement composition to treat low density lipoprotein (LDL) oxidation in humans includes a therapeutic amount of a phospholipid rich egg roe extract having at least 50 percent phospholipids and a seed oil extract in combination with astaxanthin in an oral dosage form. The astaxanthin is 0.1 to 15 percent by weight of the at least phospholipid rich egg roe extract. 1. A dietary supplement composition to treat low density lipoprotein (LDL) oxidation in humans , wherein the dietary supplement composition comprises a therapeutic amount of a phospholipid rich egg roe extract and a seed oil extract in combination with astaxanthin in an oral dosage form , wherein the astaxanthin is 0.1 to 15 percent by weight of the phospholipid rich egg roe extract.2. The composition according to claim 1 , wherein the phospholipid rich egg roe extract comprises Eiconsapentaenoic (EPA) and Docosahexaenoic (DHA) fatty acids wherein the amount of DHA is at least 50 percent greater than the amount of EPA.3. The composition according to claim 1 , comprising 150 to 500 mg of phospholipid rich egg roe extract and 0.5 to 12 mg of astaxanthin claim 1 , and wherein the composition is encapsulated into a single dosage capsule.4. The composition according to claim 1 , wherein the seed oil extract comprises an extract having an alpha-linolenic acid (ALA) to linoleic acid (LA) ratio between 1:1 and 6:1.5. The composition according to claim 4 , wherein the seed oil extract comprises a perilla seed oil extract.6perilla frutescens. The composition according to claim 5 , wherein the perilla seed oil extract comprises a supercritical CO2 fluid extracted perilla seed oil extract derived from a cracked biomass of claim 5 , the seed oil comprising from 60 to 95 percent w/w of PUFAs in a ratio from 4:1 to 6:1 alpha-linolenic acid (ALA) to linolenic acid (LA).7. The composition according to claim 1 , wherein the composition includes the phospholipid rich egg roe extract supplemented with 0.1-12 mg ...

PERILLA EXTRACT COMPOSITION

Compositions and methods for use in inhibiting mast cell activation and/or treatment or prevention of disorders associated with mast cell activation or degranulation. The compositions and methods of use include a spp. extract, such as in combination with another plant extract. The second plant extract desirably adds anti-inflammatory and/or anti-allergy properties to the compositions. 130-. (canceled)31Perilla. A composition comprising a spp. extract and another plant extract.32. The composition of claim 31 , wherein the other plant extract is an anti-inflammatory and/or an anti-allergic plant extract.33NigellaUrticaAstragalusPetasitesCitrusUncariaLavandulaMenthaEucalyptusMatricariaRosmarinusCurcumaAlliumSesamum. The composition of claim 31 , wherein the other plant extract is derived from spp. claim 31 , spp. claim 31 , spp. claim 31 , spp. claim 31 , spp. claim 31 , spp. claim 31 , spp. claim 31 , spp. claim 31 , spp. claim 31 , spp. claim 31 , spp. claim 31 , spp. claim 31 , spp. or spp.34Sesamum. The composition of claim 31 , wherein the other plant extract is derived from spp.35Perilla. The composition of claim 31 , wherein the spp. extract and/or the other plant extract is each claim 31 , independently claim 31 , obtained from the seed claim 31 , root claim 31 , leaf or whole of the plant.36Perilla. The composition of claim 31 , wherein the spp. extract and/or the other plant extract is each claim 31 , independently claim 31 , an oil.37Perillaperilla. The composition of claim 31 , wherein the spp. extract is oil and the other plant extract is sesame oil.38Perilla. The composition of claim 31 , wherein the spp. extract and the other plant extract are present in the composition in a weight ratio ranging from about 1:10 to about 10:1.39. The composition of claim 31 , wherein the composition comprises a tablet claim 31 , capsule claim 31 , caplet claim 31 , drageé claim 31 , lozenge claim 31 , granule claim 31 , powder claim 31 , pellet claim 31 , bead claim 31 , ...

A COMPOSITION HAVING A PREBIOTIC EFFECT

Provided are food, dietary supplements and/or drug compositions having prebiotic effect and their use in human and animal care. 1BacteroidesPerillaBacteroides. A method of promoting growth of probiotic bacteria in a subject and/or inhibiting the growth of pathogenic bacteria selected from the group consisting of Enterobacteriaceae , and/or Clostridia in a subject , the method comprising administering to the subject a prebiotic composition comprising a preparation in an amount effective to promoting growth of probiotic bacteria in a subject as a prebiotic and/or inhibiting the growth of pathogenic bacteria selected from the group consisting of Enterobacteriaceae , and/or Clostridia.2Perilla. The method according to claim 1 , wherein the preparation is a extract.3Perilla frutescensPerilla ocymoides. The method according to claim 1 , wherein the preparation is a or preparation.4. The method according to claim 1 , wherein the probiotic bacteria is selected from the group consisting of Bifidobacteria and Lactobacilli.5Lactobacillus bulcaricus, Lactobacillus plantarum, Lactobacillus acidophilus, Lactobacillus fermentum, Lactobacillus casei, Lactobacillus rhamnosus, Bifidobacterium bifidum, Bifidobacterium lactisBifidobacterium longum.. The method according to claim 4 , wherein the probiotic bacteria is selected from the group consisting of and6Perilla. The method according to wherein the preparation has a neutral effect to the growth of pathogenic bacteria.7Perilla. The method according to claim 1 , wherein the preparation neutralizes pathogenic bacteria.8Perilla. The method according to wherein the preparation inhibits the growth of pathogenic bacteria.9Bacteroides. The method according to claim 1 , wherein the pathogenic bacteria are selected from the group consisting of Enterobacteriaceae claim 1 , and Clostridia.10Salmonella typhimurium, Escherichia coliEnterobacter cloacae.. The method according to claim 9 , wherein the pathogenic bacteria are selected from the group ...

EYE HEALTH COMPOSITION AND METHOD USING PLANT DERIVED SEED EXTRACT RICH IN ESSENTIAL FATTY ACIDS DERIVED FROM PERILLA SEED AND CAROTENOIDS

A dietary supplement composition is formulated in a therapeutically effective amount to treat the eye of an individual. The composition includes a seed oil extract, astaxanthin, and at least one carotenoid selected from the group consisting of lutein, trans-zeaxanthin and meso-zeaxanthin. 1perilla. A dietary supplement composition formulated in a therapeutically effective amount to treat the eye of an individual , comprising a seed oil extract , astaxanthin , and at least one carotenoid selected from the group consisting of lutein , trans-zeaxanthin and meso-zeaxanthin.2. The composition according to claim 1 , further comprising 0.5 to 8 mg of astaxanthin claim 1 , 2 to 15 mg of lutein and 0.2 to 12 mg of trans-zeaxanthin on a daily basis.3. The composition according to claim 2 , comprising about 4 mg of astaxanthin claim 2 , about 10 mg of lutein and about 1.2 mg of trans-zeaxanthin.4perilla. The composition according to claim 1 , comprising about 50 to 500 mg of seed oil extract on a daily basis.5. The composition according to claim 1 , wherein the dietary supplement composition is formulated into a single dosage capsule.6Haematococcus pluvialis.. The composition according to claim 1 , wherein the astaxanthin comprises 3S claim 1 ,3′S-astaxanthin derived from7Haematococcus pluvialisHaematococcus pluvialisperillaperillaperilla. The composition according to claim 1 , comprising 3S claim 1 , 3′S-astaxanthin derived from claim 1 , lutein and trans-zeaxanthin claim 1 , wherein the 3S claim 1 ,3′S-astaxanthin derived from is 0.1 to 16 percent by weight of the seed oil extract claim 1 , the lutein is 0.4 to 30 percent by weight of the seed oil extract claim 1 , and the trans-zeaxanthin is 0.04 to 24 percent by weight of the seed oil extract in an oral dosage form.8perilla. The composition according to claim 1 , comprising krill oil supplemented to the seed oil extract.9perilla. The composition according to claim 1 , comprising an algae based oil supplemented to the seed ...

Nutritional Composition for Protecting Liver and Method for Preparing the Same

The present application discloses a nutritional composition for protecting liver. The nutritional composition comprises the following components of raw materials in parts by weight: indica rice 60-83, polished round-grained rice 11-29, lycium barbarum 1-4, finger citron 1.5-5, citron 0.05-0.2, and Chinese date 1-3.5. The present invention, in view of the liver's characteristics of preferring free activity and disliking depression, complies with the liver's physiological function characteristics for regulation, and provides the prescription based on the method of nourishing yin blood so as to disinhibit the liver, and it is suitable to cooperate with staple foods for long-term consumption, is easily accepted by people due to the good taste, and can achieve certain efficacies of soothing the liver and nourishing the liver.

SOLID DRINK FOR REGULATING YANG-DEFICIENCY CONSTITUTION AND PROCESSING METHOD THEREOF

Provided is a solid drink for regulating yang-deficiency constitution. The solid drink includes the following components of raw materials in parts by weight: 30-60, raspberry 35-55, barbarum 35-57, poria 30-54, cinnamon 35-55, fennel 20-40, ginger 33-55, dextrin 50-90, maltodextrin 23-45, soluble starch 20-44, and aspartame 0.15-0.35. The solid drink is easy to manufacture, and all the raw materials used are medicine materials of medicinal and edible dual purposes, and all the excipients used also satisfy national standard GB2760-2011 (National Food Safety Standard for Uses of Food Additives). It is safe to eat (drink) with good taste, and long-term consumption has certain effects on improving the yang-deficiency constitution. Moreover, the processing process is suitable for industrial mass production. 1perilla, lycium. A solid drink for regulating yang-deficiency constitution , comprising the following components of raw materials in parts by weight: 30-60 , raspberry 35-55barbarum 35-57 , poria 30-54 , cinnamon 35-55 , fennel 20-40 , ginger 33-55 , dextrin 50-90 , maltodextrin 23-45 , soluble starch 20-44 , and aspartame 0.15-0.35.2perilla, lycium. The solid drink for regulating yang-deficiency constitution of claim 1 , comprising the following components of raw materials in parts by weight: 40-50 claim 1 , raspberry 41-49barbarum 39-51 claim 1 , poria 38-47 claim 1 , cinnamon 41-52 claim 1 , fennel 25-35 claim 1 , ginger 37-50 claim 1 , dextrin 60-80 claim 1 , maltodextrin 27-40 claim 1 , soluble starch 25-39 claim 1 , and aspartame 0.2-0.3.3perilla, lycium. The solid drink for regulating yang-deficiency constitution of claim 1 , comprising 45 claim 1 , raspberry 45barbarum 45 claim 1 , poria 45 claim 1 , cinnamon 45 claim 1 , fennel 30 claim 1 , ginger 45 claim 1 , dextrin 69 claim 1 , maltodextrin 34 claim 1 , soluble starch 34 claim 1 , and aspartame 0.25.4. A method for processing a solid drink for regulating yang-deficiency constitution claim 1 , comprising ...

Solid Beverage for Conditioning Allergic Constitution and Method for Producing the Same

The present application discloses a solid beverage for conditioning allergic constitution. The solid beverage comprises the following components in parts by weight: 18-45 parts of smoked plum, 10-30 parts of , 18-45 parts of , 10-30 parts of purslane, 10-30 parts of seed, 10-30 parts of semen hoveniae, 7-20 parts of dahurian , 15-40 parts of dextrin, 9-23 parts of maltodextrin, 9-23 parts of soluble starch and 0.1-0.3 parts of aspartame. The solid beverage of the present application is simple and convenient to prepare, the raw materials used are all medicinal materials with dual-purpose of drug and food, and the auxiliary materials used also meet the national standard GB2760-2011 (the National Food Safety Standard for Food Additive Use). Thus, the solid beverage is safe to consume and good in taste, and has certain effects on the improvement of allergic constitution, and the production process thereof is suitable for industrial mass production. 1perilla,lilium brownii,coixangelica,. A solid beverage for conditioning allergic constitution , characterized by comprising the following components in parts by weight: 18-45 parts of smoked plum , 10-30 parts of 18-45 parts of 10-30 parts of purslane , 10-30 parts of seed , 10-30 parts of semen hoveniae , 7-20 parts of dahurian 15-40 parts of dextrin , 9-23 parts of maltodextrin , 9-23 parts of soluble starch and 0.1-0.3 parts of aspartame.2perilla,lilium brownii,coixangelica,. The solid beverage for conditioning allergic constitution according to claim 1 , characterized by comprising the following components in parts by weight: 25-35 parts of smoked plum claim 1 , 10-22 parts of 23-30 parts of 18-30 parts of purslane claim 1 , 13-25 parts of seed claim 1 , 15-26 parts of semen hoveniae claim 1 , 11-17 parts of dahurian 19-33 parts of dextrin claim 1 , 13-18 parts of maltodextrin claim 1 , 11-17 parts of soluble starch and 0.13-0.22 parts of aspartame.3perilla,lilium brownii,coixangelica,. The solid beverage for ...

Anti-Acne Formulation

A composition for the treatment of acne includes hydrolyzed containing a component bakuchiol, is solubilized in a water-based solution. The composition is for topical application to the skin. In a specific implementation, the composition is a water-based acne gel. In a specific implementation, a composition includes Bakutrol™, which includes bakuchiol, and bisabolol. The composition can include a polysorbate surfactant. In implementations, these ingredients are combined with other active ingredients, including for example, salicylic acid. A process of preparation of the composition allows for the stabilization of Bakutrol in solution. 1. A method of preparing an aqueous mixture comprising:providing a first mixture, wherein the first mixture is uniformly mixed, is aqueous, and at a temperature of about 40 to about 45 degrees Celsius;{'i': 'Psoralea corylifolia', 'providing an unsolubilized hydrolyzed extract; and'}{'i': 'Psoralea corylifolia', 'solubilizing the unsolubilized hydrolyzed extract comprising{'i': 'Psoralea corylifolia', 'mixing the unsolubilized hydrolyzed extract, bisabolol, and polysorbate 20 at room temperature to obtain a second mixture, and'}{'i': 'Psoralea corylifolia', 'adding the second mixture to the first mixture to obtain a third mixture, wherein the third mixture is at a temperature below about 40 to about 45 degrees Celsius, and the third mixture is an aqueous mixture comprising a solubilized hydrolyzed extract.'}2. A method of preparing an aqueous mixture comprising:mixing first contituents to obtain a first mixture, wherein the first mixture is provided at a temperature of 45 degrees or greater;{'i': Psoralea corylifolia', 'Psoralea corylifolia', 'Psoralea corylifolia', 'Psoralea corylifolia, 'solubilizing an unsolubilized hydrolyzed extract to obtain a solubilized hydrolyzed extract comprising mixing the unsolubilized hydrolyzed extract and bisabolol to obtain a second mixture, and adding the second mixture to the first mixture at a ...

PLANT DERIVED SEED EXTRACT RICH IN ESSENTIAL FATTY ACIDS DERIVED FROM PERILLA SEED: COMPOSITION OF MATTER, MANUFACTURING PROCESS AND USE

A composition of matter comprises a shelf stable, super critical, COfluid extracted seed oil derived from a cracked biomass of , the seed oil comprising from about 60 to about 95 percent w/w of PUFAs in a ratio of from about 4:1 to about 6:1 alpha-linolenic acid (ALA) to linoleic acid (LA) and a mixture of selected antioxidants. 1perilla frutescensperilla frutescens. A composition of matter comprising a fractionated , shelf stable , supercritical , COfluid extracted heavy fraction seed oil derived from a cracked biomass of , and made by the process of fractionating a supercritical fluid COextracted seed oil , and separating a heavy fraction from a light fraction to form the final seed oil from the heavy fraction , the seed oil comprising from 60 to 95 percent w/w of PUFAs in a ratio of from 4:1 to 6:1 alpha-linolenic acid (ALA) to linoleic acid (LA) and comprising a mixture of selected antioxidants.2. The composition of matter according to claim 1 , wherein the selected antioxidants comprise a mixture of selected lipophilic and hydrophilic antioxidants.3. The composition of matter according to claim 1 , and further comprising lipophilic antioxidants either alone or in combination with at least one of: a) phenolic antioxidants including at least one of sage claim 1 , oregano claim 1 , and rosemary; b) tocopherol claim 1 , c) tocotrienol(s) claim 1 , d) carotenoids including at least one of astaxanthin claim 1 , lutein claim 1 , and zeaxanthin; e) ascorbylacetate; f) ascorbylpalmitate g) Butylated hydroxytoluene (BHT); h) Docosapentaenoic Acid (BHA) or i) Tertiary Butyl hydroquinone (TBHQ).4. The composition of matter according to claim 1 , and further comprising a hydrophilic antioxidant or sequesterant comprising hydrophilic phenolic antioxidants including at least one of grape seed extract claim 1 , tea extracts claim 1 , ascorbic acid claim 1 , citric acid claim 1 , tartaric acid claim 1 , and malic acid.5. The composition of matter according to claim 1 , wherein ...

COMPOSITION USING SEED OIL EXTRACTS AND PHOSPHOLIPIDS TO ENHANCE ABSORPTION OF CAROTENOIDS AND ASSOCIATED METHODS

A dietary supplement composition is formulated in a therapeutically effective amount to treat the eye of an individual having an eye impairment, including dry eyes. It includes a mixture of a phospholipid and a seed oil extract having an ALA to LA ratio between 1:1 and 6:1, astaxanthin, and at least one carotenoid selected from the group consisting of lutein, trans-zeaxanthin, and meso-zeaxanthin. It is formulated into a single dosage capsule. 1. A dietary supplement composition formulated in a therapeutically effective amount to treat the eye of an individual having an eye impairment comprising a mixture of a phospholipid and a seed oil extract having an alpha-linolenic acid (ALA) to linoleic acid (LA) ratio between 1:1 and 6:1 , astaxanthin , and at least one carotenoid selected from the group consisting of lutein , trans-zeaxanthin and meso-zeaxanthin , and formulated into a single dosage capsule.2. The dietary supplement composition according to claim 1 , wherein the phospholipid comprises a phospholipid rich egg roe extract comprising at least 50 percent phospholipids.3. The dietary supplement composition according to claim 1 , wherein the phospholipid comprises at least one of Phosphatidylcholine claim 1 , Phosphatidylethanolamine claim 1 , Phosphatidylserine claim 1 , Phosphatidylinositol claim 1 , Phosphatidic acid claim 1 , Lyso-Phosphatidylcholine claim 1 , Lyso-Phosphatidylethanolamine claim 1 , and Lyso-Phosphatidylserine.4. The dietary supplement composition according to claim 1 , wherein the phospholipid is derived from at least one of a plant claim 1 , algae and animal source or synthetic derivative.5. The dietary supplement composition according to claim 1 , comprising a mixture of antioxidants admixed with the phospholipid and seed oil extract.6. The dietary supplement composition according to claim 1 , wherein the astaxanthin is derived from a natural or synthetic ester or synthetic dial.7perilla frutescens. The dietary supplement composition ...

COMPOSITION COMPRISING VICENIN-2 HAVING A BENEFICIAL EFFECT ON NEUROLOGICAL AND/OR COGNITIVE FUNCTION

The invention relates to an active ingredient and/or to a composition having beneficial effect on neurological and cognitive functions. 1. A method of maintaining and/or improving neurological and/or brain function and/or preventing , delaying onset , controlling and/or treating a neurological dysfunction , condition , disorder or disease , the method comprising administering vicenin 2 or a biologically active analogue thereof as an active ingredient to a subject in need thereof.2. The method of claim 1 , for maintaining and/or improving neurological and/or brain function.3. The method of claim 1 , wherein the neurological dysfunction claim 1 , condition claim 1 , disorder or disease is an age or stress related neurological dysfunction claim 1 , anxiety claim 1 , a cognitive disorder claim 1 , depression or dementia.4. The method of claim 1 , wherein the active ingredient is derived from a plant.5. The method of claim 4 , wherein the active ingredient is comprised in a plant preparation enriched for the active ingredient.6Anethum, Perilla, Urtica, Passiflora, Camelia, Cayaponia, Colocasia, Cydonia, Desmodium, Hordeum, Origanum, Ocimum, Jatropha, Parkinsonia, Peperomia, Piheranthos, Centaurea, Indigo, Bomba, Lychnophera, Asplenium, Chinotto, Citrus, Viola, Trigonella, Rosemary, Peppermint, Thyme, Basil, Sage, Oregano, Lavandula, Nipponanthemum, Abrus, Viola, Santalum, Oryza, Scleropyrum, Tulsi, Centaurea, Indigofera, Bombax, Glinus, Lychnophora. The method of claim 4 , wherein the plant is selected of one or more plants from a group consisting of a claim 4 , other species belonging to the Lamiacea claim 4 , Labiatae claim 4 , and Urticaceae claim 4 , Rosales or Malpighiales or a combination thereof.7. The method of claim 1 , wherein the active ingredient is derived from a plant preparation selected from the group consisting of a leaf preparation claim 1 , a fruit preparation claim 1 , a seed preparation claim 1 , a stem preparation claim 1 , a flower preparation ...

ORAL LIQUID FOR TREATING ALLERGIC COUGH

A medicine for treating allergic cough comprises 5 to 25 parts by weight of Leaf, 5 to 25 parts by weight of Periostracum Cicada, and 5 to 25 parts by weight of . The medicine is in the form of concentrated decoction, tablet, pill, granule or capsule. The medicine has effects of dispelling wind-cold, dispelling wind-heat, relieving cough and preventing asthma. The medicine provides excellent anti-allergic effect and can be used for treating allergic cough. 1. An oral liquid for treating allergic cough , comprising:{'i': 'Perilla', '5 to 25 parts by weight of Leaf;'}5 to 25 parts by weight of Periostracum Cicada; and{'i': 'lumbricus;', '5 to 25 parts by weight of'}wherein the oral liquid is a concentrated decoction.2Stemonae,phragmitesFlos Farfarae,Bulbus Fritillariae CirrhosaeExocarpium Citri Rubrum.. The oral liquid for treating allergic cough of claim 1 , further comprising 5 to 25 parts by weight of Radix Peucedani claim 1 , 5 to 25 parts by weight of Radix 5 to 25 parts by weight of stem claim 1 , 5 to 25 parts by weight of 5 to 25 parts by weight of claim 1 , and 5 to 25 parts by weight of3Perillalumbricus,Stemonae,phragmitesFlos Farfarae,Bulbus Fritillariae CirrhosaeExocarpium Citri Rubrum.. The oral liquid for treating allergic cough of claim 2 , comprising 10 to 20 parts by weight of Leaf claim 2 , 10 to 20 parts by weight of Periostracum Cicada claim 2 , 10 to 20 parts by weight of 10 to 20 parts by weight of Radix Peucedani claim 2 , 10 to 20 parts by weight of Radix 10 to 20 parts by weight of stem claim 2 , 10 to 20 parts by weight of 10 to 20 parts by weight of claim 2 , and 10 to 20 parts by weight of4. The oral liquid for treating allergic cough of claim 1 , wherein the oral liquid is used for preparing a medicine for treating allergic cough.5. A pharmaceutical preparation for treating allergic cough claim 1 , comprising:{'i': 'Perilla', '5 to 25 parts by weight of Leaf;'}5 to 25 parts by weight of Periostracum Cicada; and{'i': 'lumbricus;', '5 to 25 ...

A NASAL COMPOSITION

The present invention relates to a nasal composition comprising an anti-allergic oil derived from plant; and an oil-based barrier-forming preparation. The composition may be used in preventing and/or treating allergic disorders of the nasal cavity, including seasonal allergic rhinitis (hay fever) and perennial allergic rhinitis. 1. A nasal composition comprising:an anti-allergic oil derived from plant; andan oil-based barrier-forming preparation.2PerillaNigellaUrticaAstragalusPetasitesCitrusUncariaLavandulaMenthaEucalyptusMatricariaRosmarinusCurcumaAllium. A nasal composition according to claim 1 , wherein the anti-allergic oil is derived from the plant of spp. claim 1 , spp. claim 1 , spp. spp. claim 1 , spp. claim 1 , spp. claim 1 , spp. claim 1 , spp. claim 1 , spp. claim 1 , spp. claim 1 , spp. claim 1 , spp. claim 1 , spp. claim 1 , spp. claim 1 , or a combination of any two or more thereof.3. A nasal composition according to claim 2 , wherein the anti-allergic oil is obtained from the seed claim 2 , root claim 2 , leaf claim 2 , or whole plant parts of the plant.4. A nasal composition according to claim 1 , wherein the oil-based barrier-forming preparation contains an oily component claim 1 , one or more gel formers and an aqueous base.5. A nasal composition according to claim 4 , wherein the oily component is a hydrocarbon claim 4 , a plant oil claim 4 , a vegetable oil or hydrated claim 4 , polyoxyethylated or polyoxy- or hydrated polyoxy or fractionated derivatives thereof claim 4 , or a combination of any two or more thereof.6PerillaNigella. A nasal composition according to claim 4 , wherein the oily component is sesame oil claim 4 , and/or wherein the anti-allergic oil is derived from the plant of spp. and/or spp.7. A nasal composition according to claim 1 , wherein the anti-allergic oil and the oily component is present in a weight ratio range of about 1:10 to 10:1.8. A nasal composition according to claim 4 , wherein the one or more gel formers are for ...

PHARMACEUTICAL COMPOSITION FOR ALLEVIATING EYE FATIGUE, CONTAINING, AS ACTIVE INGREDIENTS, LUTEOLIN-7-O-DIGLUCURONIDE AND APIGENIN-7-O-DIGLUCURONIDE ISOLATED FROM PERILLA FRUTESCENS (L.) BRITTON VAR. ACUTA (THUNB.) KUDO LEAF EXTRACT

The present invention, it was confirmed that a pharmaceutical composition and a health functional food composition for alleviating eye fatigue containing, as active ingredients, compounds, particularly, luteolin-7-O-diglucuronide and apigenin-7-O-diglucuronide isolated from a (L.) Britton var. (Thunb.) Kudo leaf extract have an effect of alleviating eye fatigue by increasing the contents of NO and cGMP associated with relaxation of ciliary smooth muscle cells isolated from rat's eyes and decreasing the content of [Ca]i, and increasing cGMP which is a factor associated with relaxation of the ciliary smooth muscle through an animal experiment. As a result, the luteolin-7-O-diglucuronide and apigenin-7-O-diglucuronide compounds extracted from (L.) Britton var. (Thunb.) Kudo may be usefully used as a pharmaceutical composition and a health functional food composition having an eye fatigue alleviating effect as a Korean natural resource. 1Perilla frutescensacuta. A pharmaceutical composition for preventing and alleviating eye fatigue containing , as active ingredients , luteolin-7-O-diglucuronide and apigenin-7-O-diglucuronide compounds obtained from a (L.) Britton var. (Thunb.) Kudo leaf extract.2Perilla frutescensacuta. The pharmaceutical composition for preventing and alleviating eye fatigue of claim 1 , wherein the luteolin-7-O-diglucuronide and apigenin-7-O-diglucuronide compounds are isolated and purified by freeze-drying or spray-drying the (L.) Britton var. (Thunb.) Kudo leaf extract.3Perilla frutescensacuta. The pharmaceutical composition for preventing and alleviating eye fatigue of claim 1 , wherein the luteolin-7-O-diglucuronide and apigenin-7-O-diglucuronide compounds are isolated and purified from a water extract of (L.) Britton var. (Thunb.) Kudo leaves.4Perilla frutescensacuta. The pharmaceutical composition for preventing and alleviating eye fatigue of claim 3 , wherein the compounds are isolated and purified by adding the water extract of (L.) Britton ...

COMPOSITION AND METHOD TO ALLEVIATE JOINT PAIN USING PHOSPHOLIPIDS AND ROE EXTRACT

A dietary supplement composition and associated method has its composition formulated in a therapeutic amount to treat and alleviate symptoms of joint pain in a person having joint pain. The composition includes astaxanthin, low molecular weight hyaluronic acid or sodium hyaluronate (hyaluronan) having a molecular weight of 0.5 to 300 kilodaltons (kDa), and a phospholipid rich egg roe extract having phospholipid bound EPA and DHA admixed with seed and/or fish oil having an ALA to LA ratio of 1:1 to 6:1 and in an oral dosage form. 1. A method to treat and alleviate symptoms of joint pain in a person having joint pain by administering to a person a therapeutic amount of a dietary supplement composition comprising astaxanthin , low molecular weight hyaluronic acid or sodium hyaluronate (hyaluronan) having a molecular weight of 0.5 to 300 kilodaltons (kDa) , and a phospholipid rich egg roe extract admixed with seed oil having an alpha-linolenic acid (ALA) to linoleic acid (LA) ratio of 1:1 to 6:1 and in an oral dosage form.2. The method according to claim 1 , wherein the phospholipid rich egg roe extract admixed with seed oil contains phospholipid bound EPA and DHA.3. The method according to claim 1 , wherein the low molecular weight hyaluronic acid or sodium hyaluronate (hyaluronan) comprises pro-inflammatory low molecular weight microbial fermented sodium hyaluronate fragments.4. The method according to claim 1 , wherein the low molecular weight hyaluronic acid or sodium hyaluronate (hyaluronan) has a molecular weight of 0.5 to 100 kDa.5. The method according to claim 1 , wherein the phospholipid rich egg roe extract admixed with seed oil comprises about 15 to about 60 percent phospholipids.6. The method according to claim 1 , wherein the phospholipid rich egg roe extract admixed with seed oil comprises Eicosapentaenoic (EPA) and Docosahexaenoic (DHA) fatty acids wherein the amount of DHA is at least 50 percent greater than the amount of EPA.7. The method according to ...

COMPOSITION COMPRISING AN EXTRACT OF COMBINED HERB CONSISTING OF HEAT PROCESSED GINSENG, HOUTTUYNIAE HERBA, PERILLA LEAF AND TEA LEAF OR THE PROCESSED EXTRACT THEREOF AS AN ACTIVE INGREDIENT SHOWING HAIR-STIMULATING ACTIVITY AND PREVENTING ACTIVITY FROM HAIR LOSS, AND THE USE THEREOF.

The present invention relates to a composition comprising the extract of combined herbs consisting of heat processed , houttuyniae herba, leaf and tea leaf or the processed extract thereof as active ingredients for preventing and treating hair baldness and stimulating activity of hair growth. The inventive combined extract showed more potent hair-growth promoting activity and synergistic effect than the precedent invention(s), for example, a fermented extract of Houttuyniae Herba, leaf and Tea leaf disclosed in Korea Patent Publication No, 10-2014-0114492 (A1), through various animal model experiments such as the growth rate test using by C57BL/6 mouse, the proliferating effect on the growth of HFDPC etc and additionally, more favorable advantage than the precedent invention(s), for example, the easiness in controlling the prescribed dosage by dint of the final form of the inventive extract, i.e., concentrated solid form comparing with the solution type of the final form disclosed in precedent invention. 1ginsengperilla. A pharmaceutical composition for treating hair baldness and stimulating activity of hair growth comprising an extract of heat processed , houttuyniae herba , leaf and tea leaf , or a processed extract thereof.2ginsengginsengginsengginsengPanax ginseng, Panax quinquefolius, Panax notoginseng, Panax japonica, Panax trifolia, Panax pseudoginseng, Panax vietnamensis, Panax elegatior, Panax wangianusPanax bipinratifidus.. The pharmaceutical composition according to claim 1 , wherein said heat processed is selected from the group consisting of root claim 1 , leaf claim 1 , fruit claim 1 , and rhizome of a red or the processed produced by heating at a temperature ranging from 80 to 200° C. for a period ranging from 0.5 to 78 hours claim 1 , so as to make a ratio of ginsenoside (Rg3+Rg5+Rk1) to (Rb1+Rb2+Rc+Rd) of over 1.0 claim 1 , wherein the red is selected from the group consisting of and3. The pharmaceutical composition according to claim 1 , wherein ...

COMPOSITION FOR THE PREVENTION AND/OR TREATMENT OF ALLERGY SYMPTOMS

The present invention relates to a pharmaceutical composition or a food supplement composition and use thereof in the prevention and/or treatment of allergy symptoms, preferably allergic rhinitis and/or allergic conjunctivitis symptoms. In particular, the composition according to the invention comprises at least one slow release component comprising quercetin and at least one fast release component comprising an extract from or a constituent thereof selected from luteolin, rosmarinic acid, apigenin, catechina, ferulic acid, caffeic acid or mixtures thereof, The invention further comprises the use of the composition in the prevention and/or treatment of allergy symptoms, preferably allergic rhinitis and/or allergic conjunctivitis symptoms. 1. Composition comprising:at least one slow release component comprising quercetin; and{'i': 'Perilla frutescens', 'at least one fast release component comprising an extract from or a constituent thereof selected from luteolin, rosmarinic acid, apigenin, catechin, ferulic acid, caffeic acid or mixture thereof.'}2. Composition according to claim 1 , wherein quercetin is in the form of its glucosides and/or its salts.3Sophora JaponicaDimorphandra mollis,Sophora Japonica.. Composition according to claim 1 , wherein quercetin derives from or preferably4. Composition according to claim 1 , wherein quercetin is in a percentage from 1% to 70% claim 1 , where each % is referred to the total weight of the composition.5. Composition according to claim 1 , wherein quercetin is in the composition in an amount from 50 mg to 1000 mg.6perilla frutescens. Composition according to claim 1 , wherein the extract is water-soluble.7perilla frutescensPerilla frutescens.. Composition according to claim 1 , wherein the extract derives from leafs or seeds of8perilla frutescens. Composition according to claim 1 , wherein the extract is in a percentage from 1% to 50% claim 1 , where each % is referred to the total weight of the composition.9perilla ...

ANTI-INFLAMMATORY COMPOSITION AND COMPOSITION FOR TREATMENT OF INFLAMMATORY DISEASE, BOTH COMPRISING COMPOSITE PLANT EXTRACT

The present invention relates to an anti-inflammatory composition and a composition for treatment of an inflammatory disease, both comprising a composite plant extract and, more particularly, to an anti-inflammatory composition comprising a composite plant extract including a extract and an Koidzumi extract; a preparation method thereof; and a pharmaceutical composition comprising the composite extract for treatment of an inflammatory disease. 1Perilla frutescensAtractylodes japonica. An anti-inflammatory composition comprising a phyto-extract mixture including a Britt. extract and an Koidz. extract.2Perilla frutescens. The anti-inflammatory composition according to claim 1 , wherein the Britt. extract comprises isoegomaketone (IK) or a salt of the isoegomaketone (IK) as an active ingredient.3Perilla frutescens. The anti-inflammatory composition according to claim 1 , wherein the Britt. is Antisperill (KCTC 13077BP).4Perilla frutescens. The anti-inflammatory composition according to claim 3 , wherein the Britt. extract has an isoegomaketone (IK) content of 10 mg to 30 mg per 1 g of extract claim 3 , and an isoegomaketone (IK) concentration of 100 mg/mL to 300 mg/mL.5Perilla frutescensAtractylodes japonica. The anti-inflammatory composition according to claim 1 , wherein the Britt. extract and the Koidz. extract are extracts obtained by alcohol extraction using an ethanol solvent claim 1 , respectively.6Perilla frutescensAtractylodes japonica. The anti-inflammatory composition according to claim 1 , wherein the Britt. extract and the Koidz. extract are extracts obtained by supercritical extraction claim 1 , respectively.7. The anti-inflammatory composition according to claim 1 , wherein the phyto-extract mixture further comprises an alcohol extract by an ethanol solvent of Acanthopanaxsenticosus.8Perilla frutescensAtractylodes japonica. The anti-inflammatory composition according to claim 7 , wherein the phyto-extract mixture is formed as the other two extracts for 1 ...

THERAPEUTIC ASTAXANTHIN AND PHOSPHOLIPID COMPOSITION AND ASSOCIATED METHOD

A dietary supplement includes comprising a therapeutic amount of astaxanthin derived from a synthetic or natural ester or diol, and at least one of a phospholipid, glycolipid, and sphingolipid, and formulated into an oral dosage form, wherein the astaxanthin is 0.1 to 15 percent by weight of the at least one phospholipid, glycolipid, and sphingolipid. The composition includes 0.5 to 12 mg of astaxanthin and may be used to treat low density lipoprotein (LDL) oxidation in humans and other diseases, disorders and impairments. 1Haematococcus pluvialis. A dietary supplement composition formulated in a therapeutic effective amount to treat low density lipoprotein (LDL) peroxidation in humans composition comprising 0.5 to 12 mg of astaxanthin derived from (Hp) , and 50 to 500 mg of a lipid selected from the group consisting of a phospholipid , glycolipid , and sphingolipid , wherein the astaxanthin is 0.1 to 15 percent by weight of the lipid selected from the group consisting of a phospholipid , glycolipid and sphingolipid , and wherein the composition is formulated into an oral dosage form as a single dosage capsule.2. The composition according to claim 1 , wherein the composition further comprises a pharmaceutical or food grade diluent.3. The composition according to claim 1 , wherein the phospholipid is selected from the group consisting of Phosphatidylcholine claim 1 , Phosphatidylethanolamine claim 1 , Phosphatidylserine claim 1 , Phosphatidylinositol claim 1 , Phosphatidic acid claim 1 , Lysophosphatidylcholine claim 1 , Lysophosphatidylethanolamine claim 1 , and Lysophosphatidylserine.4. The composition according to claim 1 , wherein the phospholipid comprises at least one of a plant claim 1 , algae and animal source derivative.5. The composition according to claim 1 , wherein the composition has the astaxanthin dispersed into the selected lipid under high shear conditions.6Haematococcus pluvialis. A dietary supplement composition formulated in a therapeutic ...

COMPOSITION FOR THE PREVENTION AND/OR TREATMENT OF ALLERGY SYMPTOMS

The present invention relates to a pharmaceutical composition or a food supplement composition and use thereof in the prevention and/or treatment of allergy symptoms, preferably allergic rhinitis and/or allergic conjunctivitis symptoms. 1. Composition comprising:at least one slow release component comprising quercetin; and{'i': 'Perilla frutescens', 'at least one fast release component comprising an extract from or a constituent thereof selected from luteolin, rosmarinic acid, apigenin, catechin, acid, caffeic acid or mixture thereof.'}2. Composition according to claim 1 , wherein quercetin is in the form of its glucosides and/or its salts.3Sophora JaponicaDimorphandra mollis.. Composition according to claim 1 , wherein quercetin derives from or4. Composition according to claim 1 , wherein quercetin is in a percentage from 1% to 70% claim 1 , where each % is referred to the total weight of the composition.5. Composition according to claim 1 , wherein quercetin is in the composition in an amount from 50 mg to 1000 mg.6perilla. Composition according to claim 1 , wherein the extract is water-soluble.7perillaPerilla frutescens.. Composition according to claim 1 , wherein the extract derives from leafs or seeds of8perilla. Composition according to claim 1 , wherein the extract is in a percentage from 1% to 50% claim 1 , where each % is referred to the total weight of the composition.9perilla. Composition according to claim 1 , comprising an amount of extract from 5 mg to 500 mg.10. Composition according to claim 1 , wherein the slow release component comprises a fat-soluble compound claim 1 , selected from fatty acids C-C claim 1 , glycerides claim 1 , fatty alcohol C-Cand mixture thereof.11. Composition according to claim 1 , wherein the slow release component comprises at least one fat-soluble vitamin and/or at least one surfactant.12. Composition according to claim 1 , wherein the slow release component further comprises colecalciferol.13. Composition according to ...

COMPOSITION CONTAINING PERILLA FRUTESCENS FERMENTED EXTRACT FOR PREVENTION, ALLEVIATION, OR TREATMENT OF SLEEP DISORDER

A pharmaceutical composition, dietary supplement, or food containing a fermented extract is disclosed. The composition is useful for prevention or treatment of a sleep disorder. A composition or a fiber or fragrance composition containing a fermented extract is also disclosed. A method for treating sleep disorder employing the pharmaceutical composition, dietary supplement, food, or the fiber or fragrance composition is disclosed. 1Perilla frutescens.. A composition comprising a2Perilla frutescens.. The composition of claim 1 , wherein the fermented extract is extracted from any one or more sites selected from the group consisting of leaves claim 1 , stems claim 1 , flowers claim 1 , fruit claim 1 , and seeds of3. The composition of claim 1 , wherein the fermented extract is extracted with water claim 1 , a Cto Corganic solvent claim 1 , or a mixture thereof as a solvent claim 1 , and then fermented with a fermentation strain.4. The composition of claim 3 , wherein the fermentation strain comprises any one or more strains selected from the group consisting of bacillus claim 3 , lactobacillus claim 3 , and yeast.5BacillusBacillus subtilis, Bacillus thuringiensis, Bacillus licheniformis, Bacillus amyloliquefaciens, Bacillus stearothermophilus, Bacillus coagulans, Bacillus longum, Bacillus pumilus, Bacillus brevis, Bacillus circulansBacillus polymyxaLactobacillusLactobacillus acidophilus, Lactobacillus casei, Lactobacillus gasseri, Lactobacillus bulgaricus, Lactobacillus helveticus, Lactobacillus fermentum, Lactobacillus paracasei, Lactobacillus plantarum, Lactobacillus reuteri, Lactobacillus rhamnosusLactobacillus salivariusSaccharomycesSaccharomyces cerevisiae, Saccharomyces uvarun, Saccharomyces ellipsoideus, Saccharomyces carlsbergensis, Saccharomyces sake, Saccharomyces coreanus, Saccharomyces lipolytica, Saccharomyces boulardiiSaccharomyces pastorianus.. The composition of claim 4 , wherein the bacillus is any one or more genus bacteria selected from the group ...

用于提高透明质酸产率的组合物及其制备方法

一种特别在表皮细胞或由该细胞组成的组织中提高透明质酸产率的组合物，其中含有一种唇形科植物提取物作为活性成分，及其制备方法。尤其是，提供一种可安全和直接涂敷于人体皮肤以保持类似青年人的正常功能的化妆品或药物的组合物。

Herbal pharmaceutical composition for regenerative agent of cartilaginous tissue and treatment of osteoarthritis

본 발명은 연골 재생 및 골관절염 치료용 생약 조성물에 관한 것으로서, 보다 상세하게는 강활, 인진 및 소엽을 포함하는 연골 재생 및 골관절염 치료용 조성물에 관한 것이다. The present invention relates to a herbal composition for treating cartilage regeneration and osteoarthritis, and more particularly, to a composition for treating cartilage regeneration and osteoarthritis including vigor, jinjin and lobules. 본 발명의 조성물은 항염증 작용, 소염 진통작용, 관절 조직 분해 효소 억제 작용, 염증 유발 관련 효소 억제 작용, 발부종 억제, 관절활액의 증가 억제 작용, 관절활액의 총단백질 증가 억제 등의 치료 효능이 있어 연골 재생 및 골관절염 치료제로 이용가능하다. The composition of the present invention has an anti-inflammatory effect, anti-inflammatory analgesic effect, inhibitory effect on articular tissue degrading enzymes, inhibitory effect on inflammation-induced enzymes, inhibition of foot edema, inhibition of increase in joint synovial fluid, inhibition of total protein increase in joint synovial fluid It can be used to treat cartilage regeneration and osteoarthritis. 강활 추출물, 인진 추출물, 소엽 추출물, 프로테오글리칸, 프로스타글란딘, MMP-9, COX-2, 연골 재생제, 골관절염. Active extract, human extract, leaflet extract, proteoglycan, prostaglandin, MMP-9, COX-2, cartilage regenerant, osteoarthritis.

Composition for anti-inflammation comprising extract mixture of corn silk, perilla leaf and grape stem as effective component

본 발명은 옥수수 수염, 들깻잎 및 포도가지의 혼합 추출물을 유효성분으로 함유하는 항염용 조성물에 관한 것으로, 본 발명의 유효성분인 옥수수 수염, 들깻잎 및 포도가지의 혼합 추출물은 이들을 단독으로 사용하는 것에 비해 피부염에 의해 유도된 NO 생성을 현저하게 감소시키며, 피부염에 의한 가려움 및 피부 두께 등을 감소시키는 효과가 있다. 따라서 본 발명은 피부염의 예방, 개선 또는 치료에 효과가 있으므로, 피부염 치료제 뿐만 아니라 피부염 환자용 건강기능식품 또는 아토피 피부용 화장품 개발에 효과적으로 이용될 수 있다. The present invention relates to a composition for anti-inflammation comprising a mixed extract of corn ale, perilla leaves and grape leaves as an active ingredient, and a mixed extract of corn ale, perilla leaves and grape leaves, which are effective ingredients of the present invention, The NO production induced by dermatitis is markedly reduced, and there is an effect of reducing the itching caused by dermatitis and skin thickness and the like. Therefore, the present invention is effective for the prevention, improvement or treatment of dermatitis, so that it can be effectively used for the development of a health functional food for atopic dermatitis patients or a cosmetic for atopic skin as well as a dermatitis therapeutic agent.

Acne solution

A composition for the treatment of acne includes hydrolyzed psoralea corylifolia , containing a component bakuchiol, is solubilized in a water-based solution. The composition is for topical application to the skin. In various implementations, the composition is a water-based acne gel or a water-based cleanser. In a specific implementation, a composition includes Bakutrol™, which includes bakuchiol, and bisabolol. The composition can include a polysorbate surfactant. In implementations, these ingredients are combined with other active ingredients, including for example, salicylic acid, benzoyl peroxide, tretinoin, retinol, tazarotene, or an antibiotic, or a combination of these. A process of preparation of the composition allows for the stabilization of Bakutrol in solution.

Composition for anti-inflammatory activity and regenerative effect of cartilaginous tissue

A composition is provided to have anti-inflammatory function, analgesic activity, articulation decomposing enzyme inhibition activity, inflammation inducing related enzyme inhibition activity and foot edema, thereby being helpful to cartilaginous tissue regeneration and articulation health. The composition for regenerating cartilaginous tissue and treating osteoarthritis comprises an extract prepared by extracting a mixture consisting of 3-30 parts by weight of Artemisia capillaris Thunberg, 3-30 parts by weight of Pueraria lobata Ohwil and 4-40 parts by weight of Perilla frutescens var. acuta with a solvent selected from the group consisting of water, C1-5 alcohols and mixtures thereof. The composition decreases the amount of proteoglycan, prostaglandin, matrix metalloprotease or cyclooxygenase in blood.

Anti-inflammatory composition comprising phyto-extract mixture and composition for treatment of inflammatory diseases comprising the same

본 발명은 식물의 추출 복합물을 포함하는 항염 조성물 및 염증성 질환 치료용 조성물에 관한 것으로, 보다 상세하게는 축엽자소 추출물 및 백출 추출물을 포함하는 식물의 추출 복합물을 포함하는 항염 조성물; 이의 제조방법; 및 상기 추출 복합물을 포함하는 염증성 질환 치료용 약학적 조성물에 관한 것이다. The present invention relates to an anti-inflammatory composition comprising an extract compound of a plant and a composition for treating an inflammatory disease, and more particularly, to a anti-inflammatory composition comprising an extract compound of a plant containing an extract of axon leaf and an extract of a leaf; A method for producing the same; And a pharmaceutical composition for the treatment of inflammatory diseases comprising the above-mentioned extraction complex.

Method for extracting perilla oil and ursolic acid from perilla seeds

本发明提供一种用紫苏籽提取紫苏油和熊果酸的方法，经石油醚浸提、过柱等方法获得熊果酸和齐墩果酸晶体。该法能使紫苏充分利用，获得紫苏籽油、熊果酸和齐墩果酸产品，有效降低其生产成本，充分利用了紫苏籽中两种主要活性成份。通过树脂与结晶相结合，减少化学试剂的过度使用，保证了产品的纯天然性，可以安全的提供给食品、化妆品和制药等行业。

Astaxanthin purple perilla soft capsule and preparation method

一种虾青素紫苏软胶囊及制备方法。越来越多的研究显示抗氧化是预防衰老的重要步骤，因为自由基或氧化剂会将细胞和组织分解，影响代谢功能，并会引起不同的健康问题。如果能够消除过多的氧化自由基，对于许多自由基引起的及老化相关疾病都能够预防，例如常见的癌症、动脉硬化、糖尿病、心血管病、关节炎等，这些疾病都被认为与自由基相关。一种虾青素紫苏软胶囊及制备方法，所述的内容物原料的重量份数比：200g的雨生红球藻粉、288g紫苏籽油、15g的蜂蜡，所述的软胶囊皮原料的重量份数比：235g的明胶、117g的甘油、235g的纯化水和11.2g的焦糖色组成,以上所述的内容物和所述的软胶囊皮配比制造出的软胶囊重量为0.5g/粒。本发明应用于医药保健领域。

The non-oily extracts having anti-thrombosis activity extracted from perilla fruescens seed coat and the use thereof

본 발명은 들깨( Perilla fruescens ) 종피 추출물을 유효성분으로 함유하는 항혈전(anti-thrombosis) 조성물에 관한 것으로서, 보다 구체적으로는, 수세 후 냉풍 건조한 비파쇄 및 비가열된 들깨 종자를 95% 에탄올로 10~24시간 실온에서 종피 성분만을 추출하여 조제된 추출물 및 이의 활성 분획물을 유효성분으로 함유하는 항혈전 용도의 조성물에 관한 것이다. 본 발명의 항혈전성 조성물의 유효성분으로서의 비마쇄 및 비가열된 들깨 종자로부터 얻어진 들깨 종피 에탄올 추출물은 본 명세서의 실시예를 통해 증명된 바와 같이, 인간 혈전생성 효소 및 혈전생성인자를 특이적으로 저해하며, 특히, 열 안정성이 우수하고, pH 2의 산성조건 및 혈장 내에서도 상기 활성의 감소가 나타나지 않아, 추출액, 분말, 환, 정 등의 다양한 형태로 가공되어 항혈전성 식품, 건강 기능 식품, 약학 조성물 또는 의약품 첨가제 등의 용도에 적용되기에 매우 유용한 발명이다. The invention perilla (Perilla More particularly, the present invention relates to an anti-thrombosis composition containing an extract of Sephiroth fruescens as an active ingredient. More specifically, it relates to an anti-thrombosis composition comprising a non-disrupted and unheated perilla seed which has been washed with water after being washed with 95% ethanol for 10 to 24 hours at room temperature The present invention relates to a composition for anti-thrombotic use containing an extract prepared by extracting only a seed coat component and an active fraction thereof as an active ingredient. The perilla seed ethanol extract obtained from the non-edible and non-heated perilla seeds as the active ingredient of the antithrombotic composition of the present invention can be produced by a method comprising the step of administering a specific amount of human thrombogenic enzyme and thrombogenic factor In particular, it has excellent thermal stability and does not exhibit a decrease in the activity even in an acidic condition of pH 2 and plasma, and is processed into various forms such as extract, powder, ring, and tablet, It is an extremely useful invention to be applied to the use of pharmaceutical compositions or pharmaceutical additives.

Composition for promoting metabolic digestion and preparation method thereof

本发明属于药品和食品保健技术领域，涉及一种促进代谢消化的组合物及其制备方法，包括：110～280份紫苏籽油、135～270份沙棘籽油、42～85份番茄红素油树脂、10～55份维生素E、13～47份佛手提取物以及1～34份水果提取物；促进代谢消化的组合物中还加入辅料制成胶囊；辅料包括200～360份明胶、170～400份纯化水、50～200份甘油、1～45份蜂蜡、0.5～3.5份红曲红以及0.1～3份二氧化钛。本发明的产品安全无毒，调节促进新陈代谢水平，促进消化吸收，且营养均衡，提高免疫力，加快溃疡愈合，口感清爽，制备方法简单，原料易得，成本低。

A kind of Eczema Creams agent

本发明公开了一种含β‑葡聚糖成分的治疗湿疹、皮炎等皮肤疾病的湿疹乳膏剂，具有杀菌、消炎、保湿及淡化色素等作用，以天然植物来源的原料配方组合而成，用于护肤品、保健用品及医药产品等领域。所述湿疹乳膏剂由以下重量份的原料制成：乳化剂2～6份，天然植物油5～20份，β‑葡聚糖25～35份，马齿苋提取液2～10份，三七总皂苷0.1～2份，纯化水20～80份。

Chitosan oligosaccharide medical wound care membrane and preparation method thereof

本发明公开了一种低聚壳聚糖医用伤口护理膜及其制备方法，该医用伤口护理膜以水溶性低聚壳聚糖为基材可制成溶液剂、喷剂等，具有止血，减少组织液渗出、防止组织粘连的作用，使得产品具有良好的生物相容性、止血抗菌和保湿性能的同时，还能有效预防伤口脂肪液化，用于创面处理，可预防创面感染，促进创面快速愈合，对于慢性难愈合或烧烫伤创面的护理效果尤其显著。

Composition comprising vegetable fruit oil and vegetable seed oil and use thereof

本发明提供了一种包含植物油脂的组合物，所述植物油脂包括植物果油和植物籽油，其中，所述植物果油选自下组：乳木果油、橄榄果油、甜杏仁油、鳄梨果油、沙棘果油、椰子果油等；其中，所述植物籽油选自下组：霍霍巴籽油、红花籽油、白池花籽油、向日葵籽油、米糠油、澳洲坚果籽油、蓖麻籽油等，其中，所述植物果油与所述植物籽油的重量比为2:8至8:2，其中，以所述组合物的总重量计，所述组合物包含至少0.5重量％的植物油脂。本发明还涉及包含植物油脂的组合物在增强皮肤屏障功能和/或在制备用于增强皮肤屏障功能的药品和/或皮肤外用剂中的应用。

Medicine and food formula for specific endowment constitution of children

本发明属于药食领域，尤其涉及一种用于儿童特禀体质的药食配方。由如下重量份数的原料组成的：紫苏叶3‑9份、紫苏子3‑9份、紫苏梗3‑9份、茯苓6‑15份、佩兰6‑10份、沙棘2‑6份、荷叶2‑9份、薄荷叶（炒）5‑10份。原料成本低廉，使用方便、实用，能够有效平衡阴阳，调理脏腑，且无毒副作用。

Method for preparing caffeic acid which increases the activity of γ-UCS from perilla leaves, caffeic acid prepared therefrom, and food composition and pharmaceutical composition comprising the caffeic acid

본 발명은 들깻잎으로부터 γ-GCS의 활성을 증가시키는 카페인산을 제조하는 방법, 그로부터 제조된 카페인산, 및 상기 카페인산을 포함하는 식품 조성물 및 약학 조성물에 관한 것으로서, 더욱 구체적으로는 건조 들깻잎에 대하여 증류수를 이용한 환류 냉각추출을 수행하는 단계; 상기 환류 냉각추출 단계로부터 얻어진 추출물에 대하여 원심분리를 수행하여 상등액을 얻는 단계; 상기 상등액을 여과한 여과액을 감압농축 및 동결건조시킴으로써 들깻잎 추출 분말을 얻는 단계; 상기 들깻잎 추출 분말을 복수 개의 추출용매를 사용하여 순차적으로 추출함으로써 분획물들을 제조하는 단계; 및 상기 분획물들 중 가장 높은 γ-GCS 활성을 나타내는 분획물을 분리 및 정제하는 단계를 포함하는 들깻잎으로부터 γ-GCS의 활성을 증가시키는 카페인산을 제조하는 방법, 그로부터 제조된 카페인산, 및 상기 카페인산을 포함하는 식품 조성물 및 약학 조성물에 관한 것이다. The present invention relates to a method for producing caffeic acid which increases the activity of γ-GCS from perilla leaves, caffeic acid prepared therefrom, and a food composition and a pharmaceutical composition comprising the caffeic acid, and more particularly, to dried perilla leaves. Performing reflux cooling with distilled water; Centrifuging the extract obtained from the reflux cooling extraction step to obtain a supernatant; Obtaining perilla leaf extract powder by concentrating the filtrate obtained by filtering the supernatant under reduced pressure and lyophilization; Preparing fractions by sequentially extracting the perilla leaf extract powder using a plurality of extracting solvents; And separating and purifying the fraction showing the highest γ-GCS activity among the fractions. A method for producing caffeic acid which increases the activity of γ-GCS from perilla leaves, caffeic acid prepared therefrom, and the caffeic acid It relates to a food composition and a pharmaceutical composition comprising a. 본 발명에 따르면, 들깻잎으로부터 간편하고 저렴한 방법으로 γ-GCS의 활성을 증가시켜 간 기능을 향상시키며 강력한 항산화 효능을 갖는 카페인산을 제조할 수 있으며, 제조된 카페인산을 포함하는 식품 조성물 및 약학 조성물을 간 기능 저하 예방 및 치료에 광범위하게 활용할 수 있다. According to the present invention, a simple and inexpensive method to increase the activity of γ-GCS from perilla leaves to improve the function of the liver and can be produced caffeic acid having a strong antioxidant effect, food composition and pharmaceutical composition comprising the prepared caffeic acid It can be widely used ...

Traditional Chinese medicine composition preparation for improving leucocyte and expelling toxin and preparation method thereof

一种提升白细胞及排毒作用的中药组合物制剂及制备方法，其配方组成为紫苏、红灰菜。它可以制备胶囊剂、片剂、颗粒剂和口服液。通过优化的制备工艺，将药材内的有效成分充分提取出来，通过配伍，达到提升白细胞、血小板、改善血液循环，排出体内毒素，增强机体免疫功能。用于治疗白细胞减少症，紫癜，黄褐斑等病症，疗效显著，无毒副作用。

Oral solid self-emulsifying dispersion for treating respiratory diseases of livestock and poultry

本发明公开了一种治疗畜禽呼吸道疾病的口服固体自乳化分散体，是由以下原料药挥发油4‑7份，乳化剂2‑5份，助乳化剂1‑3份，固体分散剂载体10‑50份制备而成；其挥发油是由连翘油、桉叶油、杏仁油、桔梗油、紫苏油混配而成；固体分散剂载体为聚乙二醇。本发明采用药用级连翘油、桉叶油、杏仁油、桔梗油和紫苏油按一定比例配制成挥发油，充分利用了中药的有效成分，并与乳化剂、助乳化剂和固体分散剂载体进行结合，制备出的口服固体自乳化分散体成品纯天然无毒副作用，用于畜禽呼吸道疾病防控时，能够发挥挥发油的稳定性，提高挥发油的药效，不易产生耐药性且在畜禽体内几乎无残留，减少了对人体和环境的伤害；同时本发明生产工艺简单，便于规模化生产。

NATIONAL COMPOSITION

Composition containing Perilla seed oil for preventing or treating infertility

본 발명은 들기름(Perilla seed oil)을 유효성분으로 포함하는 불임증 예방 또는 치료용 약학 조성물을 제공한다. 본 발명의 저온압착방식으로 제조된 들기름의 자궁내막 수용력 증가 또는 착상효율증가와 관련 효과를 가지고 있어, 불임증예방 또는 치료용 약학 조성물과 불임증 예방 또는 개선용 건강기능식품 조성물 등으로 임신 착상 장애 관련하여 유용하게 활용할 수 있다. The present invention provides a pharmaceutical composition for preventing or treating infertility comprising perilla seed oil as an active ingredient. Perilla oil prepared by the low-temperature compression method of the present invention has an effect on increasing endometrial capacity or increasing implantation efficiency, so it is used as a pharmaceutical composition for preventing or treating infertility and a health functional food composition for preventing or improving infertility. It can be useful.

Composition for enhancing production capacity of hyaluronic acid and preparation method thereof

차조기과 (Labiatae) 에 속하는 식물의 식물 추출물을 유효성분으로서 함유하여 이루어지는, 특히 표피세포 또는 이 세포로 이루어지는 조직에 있어서의 히알루론산 생산능 증강용 조성물, 및 그 조제방법. 특히 인체의 피부에 안전하게 직접 적응하여 젊은 정상적인 피부기능을 유지할 수 있는 화장과학적 또는 제약학적 조성물이 제공된다. A composition for enhancing hyaluronic acid production capacity, which comprises a plant extract of a plant belonging to the group of Labiatae, as an active ingredient, in particular epidermal cells or tissues consisting of these cells, and a preparation method thereof. In particular, cosmetic or pharmaceutical compositions are provided that can safely and directly adapt to the skin of a human body to maintain normal young skin function.

Composition containing vegetable seed oil and fat and application thereof

本发明提供了一种包含植物种子油脂的组合物，其中，所述植物种子油脂选自下组：霍霍巴籽油、红花籽油、白池花籽油、向日葵籽油、澳洲坚果籽油、蓖麻籽油、牡丹籽油、葡萄籽油、葡萄柚籽油、苹果籽油、石榴籽油、西瓜籽油、西葫芦籽油、亚麻籽油、油菜籽油、芝麻籽油等或它们的组合，以所述组合物的总重量计，所述组合物包含至少0.5重量％的植物种子油脂。本发明还涉及包含植物种子油脂的组合物在增强皮肤屏障功能和/或在制备用于增强皮肤屏障功能的药品和/或皮肤外用剂中的应用。

Non-toxic mucosal disinfectant containing isopropyl alcohol, sesame oil, aloe, and lemon oil

A non-toxic mucosal disinfectant for topical application in the nose has a composition of 91 % isopropyl alcohol of at least 50 % by weight; sesame oil not exceeding 45 % by weight, lemon oil of about 2 % by weight, aloe of about 5-10 % by weight, and optional components of chlorhexidine gluconate and grapefruit seed extract. All of the components are mixed homogeneously, with the sesame oil supplementing and neutralizing the dehydrating effect of the alcohol.

A kind for the treatment of method of pair of nettle rash and eczematous dermatoses

本发明公开了一种对荨麻疹和湿疹性皮肤病的治疗方法，包括如下步骤：S1、制作涂覆皮肤上药水，所述药水涂抹在相对应的皮肤表面上，所述配方按重量份数由以下组分组成：苍术3份，黄柏3份，松香4份，五倍子5份，防风5份，蝉蜕5份，白僵蚕10份，荆芥10份，大枫子10份，白鲜皮10份，剩余是纯粮食酿造白酒；S2、制作药灸棒，点燃药灸棒放置在涂抹药水相对应的皮肤表面上；S3、口服药物。本发明能够对荨麻疹和湿疹性皮肤病治愈率高、复发率低，极大缓解了患者的痛苦，更加能够满足现代人们的需求。

Manufacturing method of red perilla leaf extract

Composition for enhancing hyaluronic acid productivity and method for preparing same

A composition for enhancing hyaluronic acid productivity particularly in epidermic cell or tissue composed of the cell. which contains an extract of a plant belonging to the family Labiatae as an active ingredient, and a process for preparation thereof. Particularly, there is provided a cosmetic or pharmaceutical composition which can be safely and directly applied to human skin to maintain the normal skin function of a juvenile.

Formulation of medicinal herbs for rhinitis and empyema

본 발명은 비염 및 축농증의 주요 원인인 비강 내 점막에 고인 누런 콧물과 농을 한방제제를 복용하여 제거함으로써, 코 막힘이 뚫리어 콧속의 비강 내 부비동의 손상된 점막이 정상 상태로 회복하여, 비염 및 축농증을 예방할 뿐만 아니라 완치하는데 뛰어난 효과가 있는 한방제제에 관한 것이다. 본 발명은 들깨 씨와 산 들깨 전초를 주약으로 하여 제조한 비염 및 축농증 치료를 위한 한방제제에 관한 것으로서, 본 발명의 한방제제는 들깨 씨 40-60 중량부, 산 들깨 전초 5-10 중량부, 신이 5-10 중량부, 창이자 5-10 중량부, 백지 5-10 중량부, 유근피 5-10 중량부, 길경 5-10 중량부 및 박하 5-10 중량부를 포함하는 것을 특징으로 하는 비염 및 축농증 치료를 위한 한방제제에 관한 것이다. 상기 방법 외에, 약효는 거의 같으나 발육기에 있는 소아나 청소년들이 복용하기 좋고, 코 막힘을 뚫어주는 효과가 복용 후 바로 나타나는 들깨 씨와 산 들깨 전초를 주약으로 하여 제조한 한방제제는 들깨 씨 40-60 중량부, 산 들깨 전초 5-10 중량부, 신이 5-10 중량부, 창이자 5-10 중량부, 백지 5-10 중량부, 유근피 5-10 중량부, 길경 5-10 중량부 및 박하 5-10 중량부를 분말하여 지름 3mm의 크기로 제조한 환약을 볶은 들깨 씨 속에 골고루 넣은 후, 꿀을 첨가하여 강정 형태로 제형화된 것을 특징으로 하는 비염 및 축농증 치료를 위한 한방제제에 관한 것이다. The present invention is based on the finding that the nasal mucosa of the nasal cavity in the nostril in the nostril is restored to a normal state by purging the nasal congestion by taking the herbal nutrient and the nasal congestion which are the main cause of rhinitis and sinusitis, The present invention relates to a herbal preparation having an excellent effect for preventing and treating sinusitis. The herbal preparation of the present invention comprises 40-60 parts by weight of perilla seeds, 5-10 parts by weight of perilla seeds, 5-10 parts by weight of perilla seeds, 5-10 parts by weight of ginseng, 5-10 parts by weight of ginseng, 5-10 parts by weight of white paper, 5-10 parts by weight of rhizome, 5-10 parts by weight of ginseng and 5-10 parts by weight of peppermint It is about herbal medicine for treatment. In addition to the above methods, the medicinal effect is almost the same, but it is good for taking pediatric or adolescents in the developing period, and the herb seed and the perilla seedlings, 5-10 parts by weight of ginseng, 5-10 parts by weight of ginseng, 5-10 parts by weight of white ginseng, 5-10 parts by weight of ginseng root, 5-10 parts by weight of ginseng, and 5- And 10 to 10 parts by weight of a pesticide prepared in ...

Composition for the prevention and/or treatment of allergy symptoms

The present invention relates to a pharmaceutical composition or a food supplement composition and use thereof in the prevention and/or treatment of allergy symptoms, preferably allergic rhinitis and/or allergic conjunctivitis symptoms. In particular, the composition according to the invention comprises at least one slow release component comprising quercetin and at least one fast release component comprising an extract from Perilla frutescens or a constituent thereof selected from luteolin, rosmarinic acid, apigenin, catechina, ferulic acid, caffeic acid or mixtures thereof, The invention further comprises the use of the composition in the prevention and/or treatment of allergy symptoms, preferably allergic rhinitis and/or allergic conjunctivitis symptoms.

A kind of chitosan oligomer medical wound nursing film and preparation method thereof

本发明公开了一种低聚壳聚糖医用伤口护理膜及其制备方法，该医用伤口护理膜以水溶性低聚壳聚糖为基材可制成溶液剂、喷剂等，具有止血，减少组织液渗出、防止组织粘连的作用，使得产品具有良好的生物相容性、止血抗菌和保湿性能的同时，还能有效预防伤口脂肪液化，用于创面处理，可预防创面感染，促进创面快速愈合，对于慢性难愈合或烧烫伤创面的护理效果尤其显著。

A kind of natural Qiang's medicine spray and preparation method thereof

本发明公开了一种天然羌药喷雾剂，包括以下重量份的组分：茹玛挥发油5‑20份、薄荷挥发油1‑5份、紫苏挥发油1‑5份、尊古巴挥发油1‑5份和苯扎溴铵1‑10份。其制备方法为：按配方称取各组分，混合，然后加入混合物80‑100倍重量的去离子水，置于搅拌机中搅拌混匀，再通过过滤机过滤，得滤液，即天然中草药喷雾剂。制备方法简单，以天然羌药为原料，成本低，安全无毒无刺激，可有效消灭肛周的各种病原微生物，其具有杀菌光谱，杀菌能力强，作用速度快，稳定性好等优点，使用后无刺激性气味，人体无不适感，不会产生副作用。

A kind of chitosan oligomer poly hexamethylene biguanide wound care film and preparation method thereof

本发明公开了一种低聚壳聚糖‑聚六亚甲基双胍伤口护理膜及其制备方法，包括如下重量百分比的各组分：包括如下重量百分比的各组分：低聚壳聚糖25~30%，聚六亚甲基双胍0.01~1%，紫草红色素1.2~1.8%，紫苏叶提取物1.2~1.8%，乳酸0.9%，余量为水。本发明将低聚壳聚糖与聚六亚甲基双胍、紫草红色素、紫苏叶提取物配合使用，成膜迅速，使创面封闭成一个理想的湿性愈合环境，提高机体的抗菌性能，细胞的增殖、分化和移行进行加快，有利于伤口周围细胞的有丝分裂、肉芽组织生长以及表皮的再生，促进了创面的加速愈合；各组方配合具有显著的生物相容性，可有效预防脂肪液化，透气性好，避免结痂及减少瘢痕的产生，使愈合后的创面更加平整光洁，具有市场推广应用前景。

Gel disinfectant for treating eczema and preparation method thereof

本发明公开了一种治疗湿疹的凝胶消毒剂及其制备方法，涉及中药凝胶制剂技术领域，由中药提取物、凝胶剂、溶剂和pH调节剂制成，所述中药提取物由紫苏油、紫皮蒜油、香椿油和金银花冻干粉组成，其中紫苏油、紫皮蒜油和香椿油分别由紫苏籽、紫皮蒜蒜皮和香椿叶提取而得，pH调节剂将凝胶消毒剂的pH值控制在6‑8。本发明以紫苏籽、紫皮蒜蒜皮、香椿叶和金银花作为中药，遵循严格的中药配伍原则，其中紫苏籽作为君药，紫皮蒜蒜皮和香椿叶作为臣药，金银花作为佐药，本申请将这三味中药作为主要成分，不仅实现了这三味中药制备湿疹治疗药物的新应用，并且所制凝胶消毒剂对湿疹具有很好的治疗效果。

Pharmaceutical composition and functional food containing perilla leaf extract of for preventing and treatment of obesity

본 발명은 깻잎 성분의 페릴알데하이드를 포함하는 지방축적억제 또는 비만 예방 및 치료용 조성물에 관한 것이다. The present invention relates to a composition for inhibiting fat accumulation or preventing and treating fat accumulation including perylaldehyde of sesame leaf components. 본 발명은 페릴알데하이드를 포함하는 지방축적억제 또는 비만 예방 및 치료용 조성물을 이용하여 약학적 제제 및 기능성 식품을 제공한다. The present invention provides a pharmaceutical formulation and a functional food using a composition for inhibiting fat accumulation or preventing and treating obesity, including perylaldehyde. 본 발명에 따른 지방축적억제 또는 비만 예방 및 치료용 약학적 제제 및 기승성 식품은 깻잎과 같은 천연물질로 부터 추출된 것을 사용하여, 생체 안전성이 우수하기 때문에, 종래 지방분해제나 비만 억제제들에 비해 독성으로 인한 각종 부작용이 없으며, 관련 질환을 앓고 있는 환자에게도 안심하고 투여할 수 있는 장점이 있다 The pharmaceutical preparations and foods for preventing fat accumulation or preventing and treating obesity according to the present invention are extracted from natural substances such as sesame leaves, and thus have excellent biosafety, compared to conventional lipolytic agents or obesity inhibitors. There are no side effects due to toxicity, and there is an advantage that it can be safely administered to patients suffering from related diseases. 페릴알데하이드, 지방축적억제, 비만, 약학적 제제, 식품 Perylaldehyde, Fat accumulation inhibitory, Obesity, Pharmaceutical preparation, Food

It is a kind of for recuperating under medical treatment the traditional Chinese medicine health care preparation of sensitive

本发明公开了一种用于调治敏感性皮肤的中药保健制剂，是由紫苏、余甘子、藿香、马齿苋、乌梅、甘草为原料药进行配伍，使各药物的功效产生协同，共凑解表清毒、生津润肤、凉血敛肺、补脾益气、行气宽中、缓急舒敏作用，全面缓解、改善并逐步解决皮肤敏感状态，从而实现抗敏脱敏、养颜美容之功能。上述临床试验表明，本发明中药制剂对皮肤敏感状态具有明显的改善和调理作用。

Method for separating and preparing active substances of perilla frutescens

本发明属于中药材领域，具体涉及一种紫苏活性物质的分离制备方法。通过预处理紫苏籽烘干、超声提取、沉降分离、滤渣纯化、滤液纯化的工艺分别制备出了高含量的紫苏多糖组分和含有多酚的抗氧化组分，避免资源浪费的同时提高了紫苏活性物质的提取效率。

Anti-oxidizing composition for scavenging free radicals, pharmaceutical composition comprising the same, and process for preparing the same

An anti-oxidizing composition for scavenging free radicals, comprising at least one essential oil component containing a number of fat-soluble, low-molecular-weight compounds, a pharmaceutical composition comprising the above composition, and a process for preparing the same are described. Percutaneous absorption of the pharmaceutical composition is effective in treating immune diseases, particularly AIDS.

Traditional Chinese medicine composition for relaxing bowel and removing freckles

本发明涉及一种润肠通便、祛斑的中药组合物，该组合物由有效成份和辅料组成，其特征在于，所述的有效成份由以下重量百分比的原料药制成：肉苁蓉21％～32％，当归16％～24％，桃仁11％～16％，桑葚11％～16％，苏子11％～16％，松花粉11％～16％。本发明所述的中药组合物治疗便秘和黄褐斑的效果显著。

Effective Perilla extract for inhibiting neuraminidase

본 발명은 뉴라미니데이즈 억제 활성을 가지는 들깨과(科) 식물의 추출물 및 이를 유효성분으로 포함하는 인플루엔자 예방 또는 치료용 조성물에 관한 것이다. 본 발명에 따르면, 들깨 추출물에 포함된 폴리페놀계 화합물들이 뉴라미니데이즈를 억제하여 인플루엔자를 예방, 치료할 수 있는 조성물, 건강식품, 가축 사료 첨가제 등을 제공할 수 있다. The present invention relates to extracts of perilla plants having neuraminidase inhibitory activity and compositions for preventing or treating influenza comprising the same as an active ingredient. According to the present invention, the polyphenol-based compounds included in the perilla extract can provide a composition, health food, livestock feed additives and the like that can inhibit and treat influenza by inhibiting neuraminidase. 들깨, 루테올린, 로즈마린산, 아피게닌, 뉴라미니데이즈, 인플루엔자, 추출 Perilla, luteolin, rosmarinic acid, apigenin, neuraminidays, influenza, extract

Co-Q10 purple perilla soft capsule prescription and preparation method

一种辅酶Q10紫苏软胶囊处方及制备方法。内容物为30g的辅酶Q10、30g的维生素E、369g的紫苏籽油、72g的蜂蜡组成,软胶囊皮为235g的明胶、117g的甘油、235g的纯化水和11.2g的焦糖色组成,内容物和软胶囊皮配比制造出的软胶囊重量为0.5g/粒，免疫力是人体自身的防御机制，是人体识别和消灭外来侵入的任何异物(病毒、细菌等)，处理衰老、损伤、死亡、变性的自身细胞以及识别和处理体内突变细胞和病毒感染细胞的能力。免疫力低下的身体易于被感染或患癌症。本发明应用于医药领域。

Combination of an antiallergic agent with a muscarinic antagonist and / or dopamine agonist for use in the prevention / arrest of axial myopia in humans.

UNO DE LOS PRINCIPALES PROBLEMAS EN CONTRA DEL USO DE ANTAGONISTAS MUSCARÍNICOS O GOTAS OCULARES AGONISTAS DE DOPAMINA, PARA EL CONTROL DEL CRECIMIENTO OCULAR Y LA PREVENCIÓN DE LA MIOPÍA, ES LA TASA INACEPTABLE DE CONJUNTIVITIS O DERMATITIS IATROGÉNICA. ESTA INVENCIÓN TIENE RELACIÓN CON LA ASOCIACIÓN DE AQUELLOS PRINCIPIOS ACTIVOS CON UN COMPONENTE ANTIALÉRGICO. EN UNA ALTERNATIVA, EL USO OFTÁLMICO DE UNA MOLÉCULA QUE SIMULTÁNEAMENTE TIENE UNA ACCIÓN ANTIMUSCARÍNICA Y/O DOPAMINÉRGICA JUNTO CON UNA FUNCIÓN ANTIHISTAMÍNICA. ONE OF THE MAIN PROBLEMS AGAINST THE USE OF MUSCARINIC ANTAGONISTS OR DOPAMINE AGONIST EYE DROPS, FOR THE CONTROL OF OCULAR GROWTH AND THE PREVENTION OF MYOPIA, IS THE INACEPTABLE RATE OF CONJUNCTIVITIS OR IATROGENIC DERMATITIS. THIS INVENTION IS RELATED TO THE ASSOCIATION OF THOSE ACTIVE PRINCIPLES WITH AN ANTIALERGIC COMPONENT. IN AN ALTERNATIVE, THE OPHTHALMIC USE OF A MOLECULE THAT SIMULTANEOUSLY HAS AN ANTIMUSCARINIC AND / OR DOPAMINERGICAL ACTION TOGETHER WITH AN ANTIHISTAMINAL FUNCTION.

Accurate medicated diet food therapy product for preventing and treating senile functional constipation and preparation method thereof

目前比较常用的治疗老年功能性便秘的制剂中大都含有大黄、芦荟等刺激性泻剂成分的药物，故不主张长时间的应用，且这些都属于药物类产品，作用比较单一，目前没有针对功能性便秘的药食同源类且改善肠道微生态的产品。本发明提出一种防治老年功能性便秘的精准药膳食疗产品及其制备方法，其产品由以下质量份的各物质组成：辣木叶1‑20、火麻仁1‑20、郁李仁1‑15、紫苏子1‑15、决明子1‑15、苦杏仁1‑15、胡麻1‑10、代代花1‑15、低聚甘露糖0.5‑3、水苏糖1‑5。本发明提供的防治老年功能性便秘的精准药膳食疗产品能够有效防治老年功能性便秘，同时本品成本低，符合产业化生产需要。

Agent for preventing or improving nocturnal pollakisuria

将迷迭香酸或其盐作为有效成分的夜间尿频的预防或改善剂。

Composition comprising Panax ginseng extract and Perilla frutescens leaves extract for preventing, ameliorating or treating of respiratory diseases caused by fine dust

본 발명은 인삼 추출물 및 깻잎 추출물의 혼합물인, 복합 추출물을 유효성분으로 포함하는 미세먼지 의한 호흡기 질환 예방, 개선 또는 치료용 조성물에 관한 것으로, 인삼 추출물의 진세노사이드와 깻잎 추출물의 로즈마리산 등의 활성성분 등으로 인하여 미세먼지 노출에 의한 모델에서 활성산소종(ROS) 생성 감소, 염증성 사이토카인 감소, 염증 활성 세포 감소 및 기도 염증 및 내피 기능장애 관련 바이오 마커(Biomarker) 및 기침 관련 유전자 발현의 감소효과가 확인되어 미세먼지 의한 호흡기 질환 예방 및 개선에 유용하게 활용될 수 있다. The present invention relates to a composition for preventing, improving or treating respiratory diseases caused by fine dust comprising a composite extract, which is a mixture of ginseng extract and sesame leaf extract, as an active ingredient, including ginsenoside of ginseng extract and rosemary acid of sesame leaf extract. Reduction of reactive oxygen species (ROS) production, reduction of inflammatory cytokines, reduction of inflammatory active cells, and reduction of airway inflammation and endothelial dysfunction-related biomarkers and cough-related gene expression in models caused by exposure to fine dust due to active ingredients, etc. As the effect was confirmed, it can be usefully used to prevent and improve respiratory diseases caused by fine dust.

Pharmaceutical composition comprising luteolin-7-o-diglucuronide, apigenin-7-o-diglucuronid isolated from perilla frutescens var. acuta leaf extract for improving ocular fatigue

The present invention relates to a health functional food for preventing and ameliorating eye fatigue, comprising luteolin-7-o-diglucuronide and apigenin-7-o-diglucuronide compounds isolated from an extract of Perilla frutescens Britton var. leaves. It is determined that active ingredients of a freeze-dried material and a spray-dried material of Perilla frutescens Britton var. leaves of the present invention contain the equal amounts of luteolin-7-O-diglucuronide and apigenin-7-O-diglucuronide compounds. Contents of NO and cGMP related to eye relaxation are increased and a content of [Ca^2+] i-ions is decreased in ciliary muscle cells (rCSMCs) isolated from rat eyes. In addition, through animal testing, a content of cGMP is increased. These compounds increase the content of cGMP in ciliary muscle cells isolated from rat eyes, thereby being usable in a composition for a health functional food for preventing and ameliorating eye fatigue.

Nanoemulsion for treating psoriasis dermatitis and preparation method and application thereof

本发明公开了一种用于治疗银屑病皮炎的纳米乳剂及其制备方法和应用，所述纳米乳剂包括油相、水相、表面活性剂和包封剂，油相为紫苏油，油相在所述纳米乳剂中的质量浓度为2％～15％；所述纳米乳剂的平均粒径为150～250nm。所述纳米乳剂中还包括抗银屑病药物，所述紫苏油的纳米液滴包埋抗银屑病药物。本发明主要基于紫苏油的促透和抗银屑病潜力，通过纳米乳剂技术，以紫苏油作为油相，解决其易挥发、易氧化问题，且该紫苏油纳米液滴具有作为难溶性抗银屑病药物载体的潜力。本发明可作为一种安全、有效的外用制剂治疗银屑病皮炎症状，提高患者的顺应性并降低治疗成本。

Anti-inflammatory and deodorant compound essential oil for sanitary products and preparation method and application thereof

本发明提供了一种可用于卫生产品的抗炎、除臭的复方精油及其制备方法与用途。包括以下制备原料：薄荷精油、桂枝精油、紫苏精油、檀香精油、香茅精油、茉莉精油，有机醇。其制备方法为将所述制备原料按照配比混合均匀即得。本发明提供的精油选用含有天然活性成分的植物精油提取而成，原料丰富，组方配比科学。全方可清热化湿，疏肝理气，共同发挥抗炎除臭的作用。经实验研究表明抗炎作用显著。

NON-TOXIC DISINFECTANTS OF Mucous membranes CONTAINING ISOPROPYL ALCOHOL, SESAME OIL, ALOE AND LEMON OIL

A kind of medicine food formula that constitution is reported for children spy

本发明属于药食领域，尤其涉及一种用于儿童特禀体质的药食配方。由如下重量份数的原料组成的：紫苏叶3‑9份、紫苏子3‑9份、紫苏梗3‑9份、茯苓6‑15份、佩兰6‑10份、沙棘2‑6份、荷叶2‑9份、薄荷叶（炒）5‑10份。原料成本低廉，使用方便、实用，能够有效平衡阴阳，调理脏腑，且无毒副作用。

Antioxidizing composition for scavenging free radicals, pharmaceutical composition comprising the same, and process for preparing the same

本发明提供至少含有1种以上内含多种脂溶性低分子化合物的精油成分并用于除去自由基的抗氧化性组合物、含有上述抗氧化性组合物的药物组合物及其制造方法。含有上述抗氧化性组合物的药物组合物经皮吸收后对免疫系统疾病特别是AIDS有效。

Method for separating and purifying antiallergic components in perilla leaves

本发明公开了一种紫苏叶中抗过敏成分的分离纯化方法，首先将新鲜紫苏叶经过常温阴干、粉碎过筛、溶剂浸泡、强化传质法进行提取，得到紫苏抗过敏粗成分，再运用薄层色谱法确定洗脱溶剂，硅胶柱层析法和葡聚糖凝胶柱层析法对紫苏抗过敏粗提物成分进行纯化，即可得到具有透明质酸酶抑制率高达89.76％的高抗过敏活性紫苏提取物。本发明提供的分离纯化方法，具有操作简单，用时少，得率高，活性显著，结果重现性好等优点，适合大多数植物活性物质的分离与纯化。

A kind of relax bowel and defecation, nti-freckle Chinese medicine composition

本发明涉及一种润肠通便、祛斑的中药组合物，该组合物由有效成份和辅料组成，其特征在于，所述的有效成份由以下重量百分比的原料药制成：肉苁蓉21％～32％，当归16％～24％，桃仁11％～16％，桑葚11％～16％，苏子11％～16％，松花粉11％～16％。本发明所述的中药组合物治疗便秘和黄褐斑的效果显著。

Agent for preventing or improving nycturia

Provided is an agent for preventing or improving nycturia, said agent containing rosmarinic acid or a salt thereof as an active ingredient.

Patent FR2442633B1

Composition for enhancing hyaluronic acid productivity and method for preparing same

一种特别在表皮细胞或由该细胞组成的组织中提高透明质酸产率的组合物,其中含有一种唇形科植物提取物作为活性成分,及其制备方法。尤其是,提供一种可安全和直接涂敷于人体皮肤以保持类似青年人的正常功能的化妆品或药物的组合物。

Perilla seed oil and silybum marianum seed oil compounded fat emulsion and preparation method thereof

本发明公开了一种紫苏籽油与水飞蓟籽油复配的脂肪乳剂及制备方法，它属于药品、保健品技术领域。紫苏籽油与水飞蓟籽油复配的脂肪乳剂，它是由下述原料按所述重量份数制备而成：紫苏籽油20~45份，水飞蓟籽油0.5~5份，磷脂0.5~3份，维生素E0.2~4份，水800~1000份。本发明采用紫苏籽油和水飞蓟籽油复配形成脂肪乳剂，有利于两种成分的实际应用，可以促进水飞蓟油的保护肝脏作用，增加了水飞蓟籽油的水溶性和生物利用度，便于服用和吸收。

Combination of an antiallergic agent with muscarinic antagonist and/or dopaminergic agonist for use in preventing/stopping of axial myopia in human

Medicine with efficacy of treating infantile asthma and preparation method and application thereof

本发明公开一种治疗小儿哮喘的药物及其制备方法，属于中药领域。本发明药物选择蜜麻黄、燀苦杏仁、炒白芍、钩藤、炒紫苏子、车前子、莱菔子、黄芩为原料，按一定的重量配比制备而成，它可以制备成任何一种常用内服剂型，具有宣肺化痰，止咳平喘的功效，用于小儿哮喘病外寒内热证，症见咳喘哮鸣，痰稠色黄，胸闷，流涕喷嚏，咽红口渴，或有恶寒发热，夜卧不安，小便黄，大便干，舌质红，苔薄白或薄黄，脉浮紧或滑数，指纹浮红或沉紫。本发明经临床验证，疗效显著，无毒副作用，有效率在96.67％以上。

Prevention or improvement agent for nocturnal frequent urination

將迷迭香酸或其鹽作為有效成分之夜間頻尿之預防或改善劑。

A kind of drug for treating gastroenteritis

一种治疗肠胃炎的药物，其特点是组分为：苏梗、黄苓、瓜蒌、木香；组分重量比：苏梗10克、黄苓8克、瓜蒌5克、木香15克；制作方法是：先用凉水浸泡30分钟，煎药前加水至没过药两指，文火煎40分钟左右，取药液约200毫升，用同法煎第二次，取药液300毫升，两次药液混合后分2次饭后服用。它解决现有治疗肠胃炎副作用大，有成瘾性，治疗时间长，停药后复发率高，不能根治等问题，适应于治疗肠胃炎使用。

Application of perilla leaf extract in preparation of medicine for preventing and treating acute lung injury

本发明公开了紫苏叶提取物在制备防治急性肺损伤药物中的应用，实验证明，紫苏叶提取物能够提高小鼠存活率，改善小鼠体重减轻，并减轻小鼠肝、脾、肺等组织的水肿；能够下调炎症因子表达,对LPS诱导的炎症风暴及免疫紊乱具有一定的抑制作用。此外，紫苏叶提取物还可以上调潮气量、每分钟通气量，对LPS诱导的呼吸功能障碍有一定的防治作用；能够明显减轻LPS尾静脉注射后各组动物出现的肺泡扩张，肺泡壁增厚，改善肺部病理状况。因此，紫苏叶提取物可以在制备防治急性肺损伤药物中的应用。

Compositions for preventing or treating infertility comprising an extract of Perilla frutescens

본 발명은 불임증 예방 또는 치료용 조성물, 임신촉진용 조성물, 또는 착상능 증진용 조성물에 관한 것으로, 더욱 상세하게는 자소엽(Perilla frutescens) 추출물을 유효성분으로 포함하는 불임증 예방 또는 치료용 조성물, 임신촉진용 조성물, 또는 난자의 자궁 내 착상능 증진용 조성물에 관한 것이다. 본 발명에 따른 자소엽 추출물은 백혈구억제인자(LIF) 및 인테그린 αvβ3와 αvβ5의 발현을 증가시키고, 모체 자궁내막세포와 태아유래 영양막세포의 결합을 촉진시켜 여성 자궁 내에서 착상 효율을 증가시키는 우수한 효과를 가지고 있는바, 불임증의 예방 또는 치료에 유용하게 활용될 수 있다. The present invention relates to a composition for preventing or treating infertility, a composition for promoting pregnancy or a composition for improving fertility, and more particularly to a composition for preventing or treating infertility comprising Perilla frutescens extract as an active ingredient, A composition for promoting ovarian cancer, or a composition for enhancing the intrauterine implantability of oocytes. According to the present invention, the self-lobular extract according to the present invention increases the expression of leukocyte inhibitory factor (LIF) and integrin [alpha] v [beta] 3 and alpha v [beta] 5 and promotes the binding of maternal endometrial cells to fetal- , It can be usefully used for the prevention or treatment of infertility.

A kind of compound chitosan oligomer wound care liquid and its preparation method and application

本发明公开了一种复合低聚壳聚糖伤口护理液，包括如下重量百分比的各组分：低聚壳聚糖35~45%，胞壁酸3~5%，纤维蛋白原0.5~3.5%，紫苏叶提取物0.5~2%，余量为水。本发明将低聚壳聚糖与胞壁酸、纤维蛋白原、紫苏叶提取物配合使用，当护理液喷涂到创面后可迅速形成透气网状结构膜，使创面封闭成一个理想的湿性愈合环境，快速止血并提高机体的抗菌、免疫性能，细胞的增殖、分化和移行进行加快，有利于伤口周围细胞的有丝分裂、肉芽组织生长以及表皮的再生，促进了创面的加速愈合；各组方配合具有显著的生物相容性，可有效预防脂肪液化，透气性好，避免结痂及减少瘢痕的产生，使愈合后的创面更加平整光洁，对于慢性难愈合或烧烫伤创面的护理效果尤其显著。

Patent RU2018133026A3

Composition for the prevention and/or treatment of allergy symptoms

The present invention relates to a pharmaceutical composition or a food supplement composition and use thereof in the prevention and/or treatment of allergy symptoms, preferably allergic rhinitis and/or allergic conjunctivitis symptoms. In particular, the composition according to the invention comprises at least one slow release component comprising quercetin and at least one fast release component comprising an extract from Perilla frutescens or a constituent thereof selected from luteolin, rosmarinic acid, apigenin, catechina, ferulic acid, caffeic acid or mixtures thereof, The invention further comprises the use of the composition in the prevention and/or treatment of allergy symptoms, preferably allergic rhinitis and/or allergic conjunctivitis symptoms.

Combination of an antiallergic agent with muscarinic antagonist and/or dopaminergic agonist for use in preventing/stopping of axial myopia in human

One of the major issues against the use of muscarinic antagonists or dopamine agonist eyedrops for the controlling of eye growth and prevention of myopia is the unacceptable rate of iatrogenic conjunctivitis or dermatitis. This invention relates to the association of those active principles with an antiallergic component. In alternative the ophthalmic use of a molecule that simultaneously has an antimuscarinic and/or dopaminergic action along with an antihistaminic function.

Use of the fruit of a plant of the genus Ocimum in the preparation of an obesity control agent

Obesity control agents and dietary control foodstuff containing, as active ingredient, the fruit of a plant of the genus Ocimum .

A kind of preparation method of nutrition and health care rose grape fruit vinegar

本发明属于果醋技术领域，尤其是一种营养保健玫瑰葡萄果醋的制备方法，具体包括以下步骤：（1）按重量份称取原料，青葡萄、鲜玫瑰花瓣、紫米、鲜苜蓿叶、鲜马齿苋、鲜紫苏叶、荸荠、醋酸菌、青春双歧杆菌、水；（2）得葡萄浆；（3）得玫瑰紫米糊；（4）得预处理葡萄果醋；（5）得营养保健玫瑰葡萄果醋；（6）真空灌装，灭菌，贴标签，得成品；酸甜可口，气味清香怡人，帮助机体新陈代谢，调节生理机能，缓解生理不顺，有效促进血液循环，促进血红素的提高，有效消除疲劳、增强体力，开胃助消化，有效杀灭肠道有害菌，促进肠道有益菌的增殖，有效降血压，缓解头晕头痛，对贫血、高血压和长期便秘的患者有显著的治疗效果。